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CHAPTER I 
INTRODUCTION 
1.1 Background 
           Atherosclerotic cardiovascular disease is the leading cause of death in the United 
States.  Cardiovascular disease (CVD) events such as a heart attack, stroke and peripheral 
arterial disease are the culmination of a disease process that begins at a young age and 
spans decades of a person’s life (Roger et al., 2012).  Although CVD rarely manifests in 
childhood, many risk factors and risk behaviors for the development and acceleration of 
atherosclerosis begin in childhood (Daniels et al., 2011).   
           Predominant risk factors for CVD are family history, age, gender, hypertension, 
dyslipidemia, overweight/obesity, diabetes, tobacco exposure, diet and physical 
inactivity.  There is increasing evidence that the number and/or severity of risk factors is 
associated with CVD and that reducing risk factors delays disease progression (Berenson 
et al., 1992; Magnussen et al., 2011).  Thus, the aim of primary prevention for children 
and adolescents is to identify and manage those at increased risk due to their identified 
risk factors with the ultimate goal of risk reduction and thwarting CVD progression 
(Raitakari et al., 2003; Webber, Srinivasan, Wattigney, & Berenson, 1991; Strong et al., 
1999).      
           Dyslipidemia is a term that describes abnormalities in lipoprotein metabolism and 
often includes elevations in total cholesterol (TC), low-density lipoprotein cholesterol 
(LDL-C) or triglycerides or deficiencies in high-density lipoprotein cholesterol (HDL-C).  
Disorders can be related to genetic conditions and/or multi-factorial with relationship to
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risk factors as described above (US Preventive Services Task Force, 2007).  Non-high-
density lipoprotein cholesterol (non-HDL-C) has recently emerged as a significant 
predictor of atherosclerosis in both children and adults.  Non-HDL-C appears to be more 
predictive than TC, LDL-C or HDL-C for detecting dyslipidemia, atherosclerosis and 
future CVD events (Frontini et al., 2008; Srinivasan, Frontini, Xu, & Berenson, 2006).  
Non-HDL-C is especially advantageous in pediatric clinical practice because it can be 
measured from non-fasting samples.  Non-HDL-C is calculated by subtracting HDL-C 
from TC which can be accurately obtained from non-fasting serum samples.  Evidence 
supports the use of non-HDL-C as a screening measure for dyslipidemia in youth and the 
most recent screening guidelines include parameters for Non-HDL-C (Daniels et al., 
2011).   
           A series of observational studies exist which clearly demonstrate the correlation of 
dyslipidemia with atherosclerotic development in youth (Daniels et al., 2011).  
Postmortem studies on children, adolescents and young adults have found significant 
associations between abnormal lipid levels and early atherosclerotic development of fatty 
streaks and fibrous plaque (Berenson et al., 1992; Daniels et al., 2011).  Childhood 
dyslipidemia is also a predictor for increased carotid intima-media thickness, which is a 
precursor for atherosclerosis (Raitakari et al., 2003).   
           Pediatric guidelines include targeted dyslipidemia screening for youth at risk 
beginning at 2 years of age and universal screening between the ages of 17 and 21 years.  
The primary risk factors used in this targeted approach are a family history of premature 
CVD or dyslipidemia (Hagan, Shaw, & Duncan, 2008).  In December 2011, the 
American Academy of Pediatrics (AAP) endorsed the Expert Panel on Integrated 
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Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents 
(Expert Panel), which added to the existing recommendations, universal screening of all 
children once between the ages of 9 and 11 years (Kavey, Simons-Morton, & de Jesus, 
2011).  This change was made in part, because recent research has shown that using 
family history of premature CVD or dyslipidemia as the primary risk factor for pediatric 
screening misses 30-60% of children with dyslipidemias (Derinoz et al., 2007).  Other 
predominant risk factors used to identify youth for targeted screening include 
hypertension, diabetes, smoking and overweight.  Of these risk factors, overweight 
children and adolescents are especially of concern given the preponderance of obesity in 
the US and the propensity of obesity itself to accelerate atherosclerosis (McGill et al., 
2001; Ogden, Carroll, Curtin, Lamb, & Flegal, 2010).   
           The American Academy of Pediatrics (AAP) follows the Centers for Disease 
Control and Prevention (CDC) body mass index (BMI) overweight percentile cutoffs to 
determine which youth meet the criteria for dyslipidemia screening.  In children and 
adolescents the preferred screening tool for weight status is the child’s BMI percentile 
distribution relative to gender and age which is derived from CDC 2000 growth charts 
(Kuczmarski et al., 2000; Daniels et al., 2011).  Overweight children are defined as those 
with BMIs at the 85
th
 percentile or greater and obese youth are those with BMIs at the 
95
th
 percentile or greater.  Overweight youth, those at the 85
th
 percentile or greater are 
considered at risk and dyslipidemia screening is advised (Barlow & the Expert 
Committee, 2007). 
           Extensive research has shown a positive relationship between adiposity status and 
CVD risk factors in youth.  However studies on the relationship of dyslipidemia and BMI 
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at the 85th percentile or greater are suggesting a need for additional research.  Research 
conducted on US children has predominantly examined the relationship of obese, not 
overweight children and the development of atherosclerosis through pathology studies, 
carotid artery imaging studies or lipid levels.  International studies have found positive 
associations between increasing levels of adiposity and more severe dyslipidemias.  
However, this research is not readily generalized to the US population because 
researchers used different classification systems for obesity and some studies were 
conducted in Asian populations whose diets are dissimilar to American western foods 
(Flechtner-Mors et al., 2011; Holl et al., 2011; Katzmarzyk, Tremblay, Perusse, Despres, 
& Bouchard, 2003; Kim Soh Ye, Hong Kyung Hee, Jang Ki Hyo, Kang Soon Ah, & 
Choue Ryo Won, 2005; Takada et al., 1998; Zhai et al., 2004).  Additionally, in a recent 
study Lee et al. (2009) found BMI did not provide effective discrimination for detecting 
youth with elevated TC or LDL-C levels.      
           National expert organizations have designated BMI at the 85
th
 percentile as the 
screening threshold for youth at risk for dyslipidemia, however additional research to 
support this cutpoint is needed.  Although, the association of childhood obesity and CVD 
is well documented, studies on US youth specific to the relationship of BMI percentiles 
and dyslipidemia are lacking.  There is a need to improve our understanding of 
overweight youth and their risk for dyslipidemias.   
1.2 Purpose of Study and Hypothesis 
           Although overweight children with BMIs at or greater than the 85
th
 percentile 
meet the at risk criteria for dyslipidemia screening, there is a scarcity of research on US 
youth that specifically study this association.  Analysis from Bogalusa researchers found 
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CDC obesity BMI cutoffs to have low sensitivity and high specificity (Freedman, Mei, 
Srinivasan, Berenson, & Dietz, 2007).  This finding is important because sensitivity and 
specificity respectively, refer to the ability of a test to correctly identify individuals with 
or without disease.  Additionally, a recent study on NHANES subjects using current 
recommended screening thresholds found that BMI did not adequately identify youth 
with abnormal TC and LDL-C levels and called into question the current screening 
recommendations (Lee et al., 2009).  Given the prevalence of overweight and obese 
youth in the United States, screening recommendations based on a threshold of the 85
th
 
BMI percentile results in a large number of children and adolescents to receive 
dyslipidemia screening.    
           The purpose of this research is to add to the body of knowledge on childhood and 
adolescent weight categories and their association with dyslipidemia.  This research seeks 
to elucidate whether US youth with BMIs at the 85
th
 percentile or greater are at increased 
risk for dyslipidemia compared to children and adolescents who are at a healthy weight.   
The study group will consist of youth 6 to 18 years of age who participated in NHANES 
during the cycle years from 2007 to 2010.  The objective of using sample groups from the 
latest NHANES surveys is to more closely mirror the current US population.  The study 
hypothesizes that children and adolescents who are overweight are at greater risk for 
dyslipidemia compared to normal weight youth.
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CHAPTER II 
REVIEW OF THE LITERATURE 
2.1 Cardiovascular Disease 
           Cardiovascular disease (CVD) is the leading cause of death and disability 
worldwide.  In 2008, 17.3 million deaths occurred worldwide due to CVD.  Of these 
deaths, 7.3 million were from heart attacks and 6.2 million from strokes (Mendis, Puska, 
& Norrving, 2011).  In the United States, for the past 90 years CVD has accounted for 
more deaths than any other cause.  Approximately one in three persons in the United 
States has some form of CVD and one in three deaths are attributed to CVD.  
Cardiovascular disease causes more deaths each year than cancer, accidents and chronic 
lower respiratory diseases combined (Lloyd-Jones et al., 2009).   
          Cardiovascular disease includes diseases of the heart and vascular diseases of the 
blood vessels to the heart, brain and peripheral arteries.  In the adult, acute CVD events, 
such as myocardial infarction and stroke, occur after the long-term development of 
atherosclerosis and thrombotic events associated with atherosclerotic plaque instability.  
In pediatrics, the primary component of this process is the development of 
atherosclerosis, because CVD thrombosis does not occur in the absence of 
atherosclerosis.  Although CVD in children and adolescents is rare, risk factors and 
behaviors that contribute to atherosclerosis often begin in childhood and there is 
increasing evidence that reducing these risk factors can delay progression of 
atherosclerosis and eventual CVD (Daniels et al., 2011).
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2.2 Expert Guidelines and Recommendations 
           To address this health issue, in 2006, an Expert Panel was appointed by the 
National Heart, Lung, and Blood Institute (NHLBI) to conduct a formal evidence review 
and to develop cardiovascular health and risk reduction guidelines for pediatric care 
providers.  The Expert Panel’s approach to this guideline development was characterized 
by formal evidence review and integration of multiple major CVD risk factors into one 
document.  The Full Report of the Expert Panel is available on the NHLBI website and 
these Expert Panel guidelines were endorsed by the American Academy of Pediatrics 
(AAP) in 2011 (Daniels et al., 2011).   
           Prior to release of the Expert Panel’s report, guidance for dyslipidemia screening 
in children was primarily presented through two publications, the AAP policy statement 
Lipid Screening and Cardiovascular Health in Childhood and Bright Futures 3
rd
 Edition 
Guidelines.  The AAP policy statement, published in 2008, presented three different sets 
of guidelines to use in determining normal and abnormal lipid levels.  One set of 
guidelines was adapted from the 1992 National Cholesterol Education Program: Report 
of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.  Another 
was adopted from the American Heart Association, while a third, percentile ranking 
table, was adapted from the Lipid Research Clinic Pediatric Prevalence Study.  Although 
the National Cholesterol Education Program (NCEP) and AAP recommend a targeted 
approach to screen children with certain risk factors (i.e., family history of premature 
CVD or hypercholesterolemia, diabetes, hypertension and obesity) research to optimize 
screening protocols has not led to consensus in pediatric screening (Daniels, Greer, & the 
Committee on Nutrition, 2008).  
8 
 
    
   
           In 2007, the US Preventive Services Task Force (USPSTF) (2007) concluded that 
evidence was insufficient to recommend for or against routine screening for dyslipidemia 
in youth and young adults up to age 20.  The USPSTF could not address key questions 
about screening and treatment of dyslipidemia in children and adolescents because 
studies were lacking.  However, due to the nature of pediatric research, pediatric 
prevention unfortunately is often based upon less rigorous scientific evidence, and 
“Insufficient” recommendations from the USPSTF are not uncommon (Daniels, Greer, & 
Stettler, 2008; Moyer & Nelson, 2008).  The lack of studies in this area of pediatric 
research is due in part because longitudinal studies linking childhood risk factors to CVD 
would involve extensive periods of time in the range of 50 to 60 years duration and 
clinical trials of voluntary risk exposure in children are unethical (Daniels et al., 2011).      
           The recent report of the Expert Panel on Integrated Guidelines for Cardiovascular 
Health and Risk Reduction in Children and Adolescents is a comprehensive review and 
critical appraisal of every relevant study available on the multiple risk factors for CVD 
development, progression and management.  The Expert Panel followed an Evidence 
Grading System adapted from the American Academy of Pediatrics Steering Committee 
on Quality Improvement and Management.  The Expert Panel assigned the Evidence 
Review for Lipid Assessment in Childhood and Adolescence a Grade B (strongly 
recommended).  Evidence for a Grade B was based on randomized controlled trials or 
diagnostic studies with minor limitations, genetic natural history studies, and/or 
overwhelmingly consistent evidence from observational studies.  The definition for a 
strong recommendation as included in the report is that the benefits clearly exceed the 
harms and that the quality of the supporting evidence is excellent.  In some 
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circumstances, strong recommendations were made on the basis of lesser evidence when 
high-quality evidence was impossible to obtain and the anticipated benefits clearly 
outweighed the harms.  Unlike earlier policy statements and guidelines, the Expert Panel 
Report has integrated the evidence and produced conclusive detailed tables and 
algorithms to follow for lipid assessment that address age variance.  The Expert Panel 
determined that CV risk reduction in children and adolescents addresses the disease 
process atherosclerosis, in which the clinical endpoint of manifest CVD occurs much 
later in life (Daniels et al., 2011).        
2.3 Atherosclerosis 
           Atherosclerosis is responsible for a large proportion of cardiovascular diseases.  It 
is an underlying pathological process in the blood vessels that develops over many years.  
In atherosclerosis, plaque which consists of fatty substances and cholesterol, builds up in 
arteries.  Over time the plaque hardens and the arterial lumen narrows with resultant 
decreased blood flow and potential clot formation.  The atherosclerotic process often 
leads to disruption of blood supply to vital organs such as the heart and brain, resulting in 
cardiac and cerebral events (Mendis, Puska, & Norrving, 2011). 
           The earliest sign of atherosclerosis is the fatty streak, which is an accumulation of 
lipid-filled macrophages in the intimal layer of the artery.  Progression of atherosclerosis 
occurs with accumulation of smooth muscle cells and fibrous tissue produced by the fat 
laden smooth muscle cells.  Over time the fatty streak evolves into a fibrous plaque, the 
hallmark of established atherosclerosis.  The buildup of plaque restricts blood flow by 
narrowing arteries, hardening arterial walls and clot formation.  Cessation of blood 
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supply causes lack of oxygen and tissue infarction, which damages the affected tissues or 
organs (Crowther, 2005; Daniels, Greer, & the Committee on Nutrition, 2008). 
2.4 Childhood Risk Factors for Adult CVD 
           Most of the clinical burden of atherosclerosis occurs in middle to older adulthood, 
but the pathological process of atherosclerosis begins in childhood (Juonala et al., 2010).  
Pathology studies have confirmed the atherosclerotic process begins at a young age.  
Autopsy studies of young soldiers killed in the Korean and Vietnam Wars found evidence 
of atherosclerosis (Enos, Homes, & Beyer, 1953; McNamara, Molot, Stremple, & 
Cutting, 1971).  In the Korean War study, 300 soldiers who were battle casualties were 
examined for gross lesions in the coronary arteries.  The ages of the first 98 soldiers were 
not recorded, except that the oldest was 33 years of age.  The average recorded age of the 
remaining 200 soldiers was 22 years of age, ranging from 18 to 48 years.  Cases with 
known clinical evidence of coronary disease were excluded from the study.  Findings 
indicated 77% had evidence of atherosclerosis (Enos, Homes, & Beyer, 1953; Le, Zhang, 
Menees, Chen, & Raghuveer, 2009).  In the Vietnam War study, postmortem 
examination of 105 soldiers with coronary angiography and heart dissection revealed 
45% with some evidence of atherosclerosis and 5% with gross evidence of severe 
coronary atherosclerosis (McNamara et al., 1971).   
           The study, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) was 
a multi-institutional study which was initiated to document the natural history of 
atherosclerosis, its relationship to risk factors, and the pathobiology of lesion 
development in young subjects (Strong for the Pathobiological Determinants of 
Atherosclerosis in Youth (PDAY) Research Group, 1995).  PDAY studies conducted 
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from 1987 to 1994, examined subjects from 15 to 34 years of age, because this is the age 
when fatty streaks are prevalent and fibrous plaques begin to appear (Strong et al., 1999).  
This study included 1079 males and 364 females, black and white, who died from 
external causes (suicide, homicide and accidents). 
           PDAY studies have described the effects of age, sex, race, dyslipidemias, 
smoking, hypertension, diabetes and obesity on the microscopic development of 
atherosclerosis in youth and young adults.  The extent of arterial intima involved with 
fatty streaks and raised lesions increased with age in both sexes and race groups.  
Investigators found strong relationships between the degree of atherosclerosis and the 
extent of known risk factors, including increasing age, increasing levels of non-HDL-C, 
lower HDL-C, hypertension, impaired glucose tolerance, smoking, and obesity in males.  
The severity of atherosclerosis was markedly increased in subjects with multiple risks 
(McGill et al., 2001; Strong for the Pathobiological Determinants of Atherosclerosis in 
Youth (PDAY) Research Group, 1995).    
           PDAY researchers devised youth risk scores for predicting advanced 
atherosclerotic lesions using modifiable risk factors of dyslipidemia, tobacco use, 
hypertension, obesity and hyperglycemia.  Subjects with higher risk scores had 
significantly higher odds ratios for atherosclerotic lesions.  The prevalence of advanced 
atherosclerosis in the high-risk 15 to 19 year olds was nearly the same as low-risk 30 to 
34 year old subjects (McMahan et al., 2006).   
           The Bogalusa Heart Study was a long-term epidemiologic study of cardiovascular 
disease risk factors in persons from birth through 38 years of age.  The study began in 
1973 in the biracial community of Bogalusa, Louisiana.  Bogalusa investigators 
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performed autopsy studies on 204 persons, 2 through 39 years of age.  The causes of 
death varied, but principally were due to accidents and homicide.  Subjects were 
evaluated for extent of atherosclerotic lesions in the aorta and coronary arteries.  
Investigators found the extent of fatty streaks and fibrous plaque increased with age.  
This age related trend was especially significant in the coronary arteries where the 
prevalence of fibrous plaques increased from 8% in the 2 to 15 year old group, to 69% in 
the 26 to 39 year old group (Berenson et al., 1998). 
           In the Bogalusa study, investigators conducted six cross-sectional surveys which 
included over 3,500 children.  The first survey examined 5 to 14 year old subjects.  
Subsequent surveys were conducted throughout school age and beyond high school.  
Findings from Bogalusa report on the positive association of cardiovascular risk factors, 
body mass index (BMI), blood pressure, lipid levels and the development of 
atherosclerosis in the aorta and coronary arteries (Berenson et al., 1998; Berenson et al., 
1992; Newman et al., 1986).     
           Two large studies utilized ultrasonography, a non-invasive method, to detect 
atherosclerosis by measurement of carotid artery intima-media thickness (IMT), a 
surrogate measure for CVD.  The validity of using carotid IMT as a reliable marker for 
atherosclerosis is well documented (de Groot et al., 2004; Roger et al., 2012).  The 
Rotterdam Study and the Atherosclerosis Risk in Communities (ARIC) Study found that 
carotid IMT correlates positively and significantly with vascular risk factors and 
cardiovascular disease.  Additionally, in the ARIC study, carotid ultrasonography was 
able to determine all stages of atherosclerosis (Bots, Hoes, Koudstaal, Hofman, & 
Grobbee, 1997; Heiss et al., 1991. 
13 
 
    
   
           The Muscatine study was a longitudinal cohort study which began in 1971 with 
biennial examinations of school children 8 to 18 years of age in Muscatine, Iowa.  
Ultrasonography was used in the Muscatine study in the 1990s to determine the 
relationship of higher carotid IMT with cardiovascular risk factors that occurred in 
childhood and beyond.  The study included 725 male and female participants who had 
previously participated in at least one childhood survey and had reached the age of 33 to 
42 years.  In this cohort, childhood risk factors measured as early as 8 to 11 years of age 
and predictive of high adult carotid IMT were TC for both men and women and BMI for 
women (Davis, Dawson, Riley, & Lauer, 2001).   
           In the Bogalusa study, investigators measured carotid IMT to evaluate the 
influence of gender, ethnicity and risk factors on early stages of atherosclerosis.  The 
study included 518 male and female subjects, with a mean age of 32 years.  The subjects 
were overweight, but otherwise healthy, asymptomatic young adults.  Cardiovascular risk 
factors evaluated included obesity, hypertension, dyslipidemia, hyperinsulinemia and 
smoking.  After adjustments for age, race and sex, carotid IMT was associated 
significantly and positively with waist circumference, systolic blood pressure, diastolic 
blood pressure, and LDL cholesterol.  Carotid IMT was inversely correlated with high-
density lipoprotein (HDL) cholesterol levels.  Participants with greater numbers of 
adverse risk factors had stepwise increases in mean carotid IMT levels (Urbina et al., 
2002).   
           Probably the most compelling evidence that childhood dyslipidemia risk factors 
are related to adult CVD is the manifestation of cardiovascular conditions.  Familial 
hypercholesterolemia (FH) is an autosomal dominant disorder characterized by 
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abnormally high concentrations of LDL-C.  FH is one of the most common inherited 
disorders with an estimated worldwide prevalence of 1 in 500 (Austin, Hutter, Zimmern, 
& Humphries, 2004).  The dyslipidemia associated with FH leads to increased risk for 
CVD and death.  Risk for coronary heart disease (CHD) and cardiac events is much 
higher with 50% of FH men and 25% of FH women experiencing clinical coronary 
events by 50 years of age (Neil et al., 2008; Stone, Levy, Fredrickson, & Verter, 1974).  
Adding to the evidence of causation, the use of statin medications to reduce dyslipidemia 
in FH subjects has been shown to reduce morbidity and mortality (Neil et al., 2008).  
Furthermore, the ARIC study found that persons with genetic traits associated with low 
cholesterol had conferred protection against CHD and significantly lower measures of 
carotid IMT (Cohen, Boerwinkle, & Hobbs, 2006).  Collectively these studies helped to 
establish the association of childhood dyslipidemia as a risk factor for adult CVD.  
2.5 Childhood Risk Factors Track into Adulthood 
           Risk factors for CVD and atherosclerosis can be categorized as life conditions 
(e.g., family history, age, gender), pathophysiologic (e.g., hypertension, dyslipidemia, 
overweight, diabetes), behavioral (e.g., tobacco exposure, nutrition, physical activity) and 
emerging (e.g., metabolic syndrome, inflammatory markers, perinatal factors) (Daniels et 
al., 2011).  The strongest risk factors include obesity, dyslipidemia, hypertension, 
diabetes, and tobacco use (Daniels, Greer, & The Committee On Nutrition, 2008; Wilson 
et al., 1998).  Research has demonstrated that these pathophysiologic risk factors can be 
present at young ages and track into adulthood (Berenson et al., 1998; Juonala et al., 
2005).  A detailed review of all risk factors is beyond the scope of this thesis.  Obesity 
and dyslipidemia, individually, are broad topics.  Because obesity and dyslipidemia as 
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screening indices in childhood are the focus of this study, this literature review will aim 
to present research findings relevant to childhood overweight/obesity and its’ associations 
with dyslipidemia, although brief mention of other risk factors and related components of 
overweight/obesity and dyslipidemia may be included.       
           In epidemiologic studies, tracking describes consistency and longitudinal 
development of risk factors over time (Magnussen et al., 2011; Twisk, Kemper, & 
Mellenbergh, 1994).  From a pediatric viewpoint, tracking analyses are beneficial 
because they can predict future values from early life measurements and aid in 
determining which risk factors to target for primary prevention or treatment.  Tracking 
indicators are generally correlations between repeated measurements of an attribute at 
different times and the proportion of participants that remain in the group.  Due to 
established associations of dyslipidemia and CVD in adults, blood lipid levels have been 
studied for tracking in children and adolescents.   
           A number of prospective studies on the tracking of lipids from youth into 
adulthood exist.  In the Bogalusa Heart Study, a study cohort was derived and monitored 
for an average of 27 years.  There were 1163 subjects, 30% black and 55% female who 
were 5 to 14 years at baseline.  Investigators studied persistence of ranking of non-HDL-
C and LDL-C levels in quintile levels from childhood to adulthood.   For both cholesterol 
levels 66% of subjects who were above the 60th percentile in childhood remained above 
the 60th percentile as an adult.  Of the variables studied, baseline levels of non-HDL-C 
and LDL-C were the best predictors for adult levels with standardized regression 
coefficients of 0.36 and 0.40 respectively.  Change in BMI from childhood to adulthood 
was the next best predictor for both variables with standardized regression coefficients of 
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0.20 for non-HDL-C and 0.22 for LDL-C.  Children in age-, gender- and race-specific top 
quartiles of non-HDL-C and LDL-C were compared to those in the bottom quartiles and 
had odds ratios of 4.5 and 3.5 respectively to develop dyslipidemia (Srinivasan, Frontini, 
Xu, & Berenson, 2006). 
           Muscatine investigators found that increased cholesterol values during childhood 
were associated with increased values as adults.  A cohort of 2446 subjects were initially 
examined at 8 to 18 years of age, then re-examined between 20 to 30 years of age.  
Eighty one percent of children who had cholesterol values above the 50
th
 percentile 
remained above the 50
th
 percentile as an adult.  Of those that were at or above the 75
th
 
percentile, 62% remained at this level as an adult.  For the highest level at or above the 
90
th
 percentile, 43% remained as adults.  Fifty to 87% of children whose cholesterol 
levels exceeded the 90
th
 percentile were above the 75
th
 percentile as adults.  Conversely, 
if children’s cholesterol levels were less than the 90th percentile, 78 – 84% were below 
the 75
th
 percentile as adults.  The 75
th
 percentile cutoff was used in this study because it 
was the National Cholesterol Education Program recommended benchmark to implement 
dietary interventions in adults with dyslipidemias (Lauer, Lee, & Clarke, 1989).   
           In the Cardiovascular Risk in Young Finns Study tracking and predictiveness of 
lipid measurements of Finnish youth were analyzed over a 12 year period.  The cohort 
included 883 subjects from 3 to 18 years of age with 47% male.  Spearman’s correlation 
coefficients for 12–year tracking were as follows:  TC 0.48-0.58, LDL-C 0.53-0.58, 
HDL-C 0.53-0.58, LDL:HDL cholesterol ratio 0.57-0.59 and triglycerides 0.33-0.37.  
Approximately 50% of participants who were in the extreme quintiles for TC, LDL-C 
and HDL-C on initial exam remained in the same quintiles after 12 years.  In multiple 
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regression analyses, conducted by Porkka, Viikari, Taimela, Dahl, and Akerblom (1994) 
childhood obesity, exercise, diet, and smoking habits did not markedly aid the prediction 
of adult serum lipid values. 
           Friedman (2006) found a wide range of test agreement values in tracking of lipid 
abnormalities from childhood to adulthood.  The Princeton Lipid Research Clinics 
Prevalence Program Follow-Up Study was a prospective study to determine sensitivity 
and specificity of National Cholesterol Education Program (NCEP) pediatric cutoff 
points during youth for adult lipid status.  The derived cohort included children 5 to 19 
years of age when initially studied in the Cincinnati Clinic of the Lipid Research Clinics 
(LRC) Prevalence Study from 1972-1978.  Study participants for the Princeton Follow-
Up Study (PFS) were students in 1
st
 to 12
th
 grade in public and parochial schools in the 
Princeton School District.  The study group was 73% white, 27% black, 52% male and 
48% female.  A total of 844 subjects were evaluated for LDL-C tracking and 897 subjects 
for TC tracking.  Guidelines from the NCEP were followed for determining adult 
elevated TC and LDL-C levels (Friedman, 2006).     
           Reported overall sensitivities were 43 to 46% and specificities were 82 to 86% for 
total and low-density lipoprotein cholesterol levels respectively.  The positive predictive 
values were 39% for TC and 31% for LDL-C.  Negative predictive values were 88% for 
TC and 91% for LDL-C.  Researchers examined sensitivity and specificity of the entire 
cohort according to age.  Sensitivities ranged from 18% (16 years old) to 63% (11 years 
old) for TC, and 22% (15 years old) to 69% (9 years old) for LDL-C.  The highest 
sensitivities occurred in the younger age groups between 5 and 11 years of age and the 
lowest occurred at 14 to 16 years of age.  Sensitivities seemed to be increasing in the 17 
18 
 
    
   
to 19 year old groups (~49% TC and ~65% LDL-C) to levels similar to the younger ages.  
The specificities were high ranging from 77 to 96%.  This study was especially of merit 
in delineating the variability in sensitivities at different ages.     
           Childhood to adult lipid tracking was described in another prospective study by 
Stuhldreher et al., (1991).  In the Beaver County Lipid Study investigators conducted 
follow-up screening on 295 adults who had initially participated as children in a school-
based screening program at the ages of 11 to 14 years.  The follow-up phase of the study 
was conducted 16 years after the baseline study conducted in 1972 -1973 when the 
subjects had reached a mean age of 28 years.  Overall correlation coefficients between 
the baseline and follow-up study for TC levels were 0.44 (P<0.0001).  Correlation 
coefficients for women were higher (r = 0.51) compared to men (r = 0.38).  Based on 
recommended guidelines, cutoffs for elevated TC levels or positive test results were 
established at 175 mg/dl in children and 200 mg/dl in adults.  Researchers reported 
sensitivity of 63%, specificity of 67% and a positive predictive value of 47% for 
screening at 12 years of age and predicting elevated adult TC levels.   
           For this Beaver study, a false-positive test was a child who was above the cutoff as 
a child, but not as an adult.  A false-negative test was a child who was below the cutoff as 
a child, but not as an adult.  A comparison of test results found that male and female 
subjects with false-positive results smoked significantly less than those with false-
negative results.  In addition, false-positive males had a greater improvement between 
evaluation periods in cholesterol-lowering dietary practices.  Comparisons also revealed 
that female subjects with false-positive results were less overweight and had a lower 
prevalence of oral contraceptive use.  Researchers surmised that although some subjects 
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were misclassified as a result of childhood screening, some misclassification was 
associated with adopting changes that would be promoted through a screening and 
intervention program such as tobacco cessation, achieving healthy weight and dietary 
changes.    
2.6 Childhood Obesity Tracks into Adulthood 
           Of all the aforementioned pathophysiologic risk factors, obesity tracks from 
childhood to adulthood the strongest (Daniels et al., 2011).  Childhood levels of obesity 
are epidemic in the US and since 1980 obesity prevalence in school aged children has 
tripled.  Data from the 2007 National Survey of Children’s Health and the 2007-2008 
NHANES find approximately 32% of youth are overweight and approximately 17% are 
obese (Odgen, Carroll, Curtin, Lamb, & Flegal, 2010 ; Singh, Kogan, & van Dyck, 
2010).  Reports from the most recent NHANES survey 2009-2010 indicate no change in 
childhood obesity prevalence from 2007-2008 (Ogden et al., 2010).  
           Centers for Disease Control and Prevention (CDC) growth charts with BMI 
percentiles relative to age and gender are the preferred reference to identify overweight 
and obesity in youth from 2 to 18 years of age.  Expert committee recommendations with 
representation from 15 national health care organizations, recommend using BMI on 
individual children in order to assess weight-for-height relationships.  BMI as an obesity 
measure has limitations such as, it does not directly measure body fat, and does not take 
into account skeletal size or muscle mass (Wilk, 2007).  Thus, a very muscular person 
may have a BMI which falls into an overweight category.  Although there are some 
limitations, BMI is easily calculated, correlates strongly with direct measure of body fat 
and has acceptable accuracy especially in identifying individuals with higher amounts of 
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body fat, e.g. those above the 85
th
 percentile.  The expert committee convened by the 
American Medical Association, the CDC and the Maternal and Child Health Bureau 
(MCHB) has defined childhood and adolescent obesity as a BMI at or greater than the 
95
th
 percentile and BMIs between the 85
th
 and 94
th
 percentiles as overweight (Barlow & 
the Expert Committee, 2007; Daniels et al., 2011).    
           Investigators from the Bogalusa Heart Study reported that childhood BMI is 
associated with adult obesity.  In this study with over 2600 participants, 77% of obese 
youth (BMI at or greater than the 95
th
 percentile) remained obese (BMI at or greater than 
30 kg/m²) as an adult.  Children 2 to 17 years of age were re-examined at 18 to 37 years 
of age.  The mean follow-up time was 17 years.  The magnitude of correlations between 
childhood and adult obesity increased with age of childhood measurement.  The BMIs of 
2 to 5 year olds were moderately associated with Spearman’s correlation coefficients at 
0.50 and 0.45 for males and females respectively.  Associations increased with age with 
the strongest BMI association occurring in 15 to 17 year old adolescents 0.74 and 0.66 
for males and females respectively (Freedman, Khan, Dietz, Srinivasan, & Berenson, 
2001; Freedman et al., 2005).    
           Muscatine researchers report even higher tracking correlations for BMI that range 
from 0.58 to 0.91.  This study involved 2631 children from 9 to 18 years of age that were 
followed into their young adult life and re-examined between the ages of 23 and 33 years.  
An interesting finding in this study was that approximately 31% of children in the top 
quintile of BMI became adults that fell into a much lower weight category and that 
approximately the same percentage of lean children became obese adults.  Similar to the 
Bogalusa study, Muscatine investigators also found tracking associations increased as 
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childhood age increased with correlations of adult Quetelet Index (weight divided by 
height²) lowest at 0.45 in the 7 to 8 year old female group and reaching a maximum of 
0.74 in the 13 to 14 year old males (Clarke & Lauer, 1993).   
           In the National Heart, Lung and Blood Institute Growth and Health Study (NGHS) 
a cohort of 2379 bi-racial females were examined annually from the age of 9 or 10 
through 18 to 19 years of age.  NGHS-Wave II was conducted as a follow-up telephone 
interview when the subjects were between 21 to 23 years of age.  There were 2054 
participants in NGHS-Wave II which included 991 Caucasians and 1063 African-
American girls.  Overweight in youth up to 18 years of age was defined by attainment of 
the 95
th
 percentile for BMI, and for young adults 21 years of age and older BMI was 
defined as at or greater than 30 kg/m².  Study participants who were overweight from age 
9 to 18 years were 11 to 30 times more likely to be obese as adults compared to not 
overweight girls.  Investigators noted the limitation that self-reported body measurements 
in the follow-up study presented, but nonetheless found these strong associations 
noteworthy (Thompson et al., 2007).   
2.7 BMI as a Predictor for Dyslipidemias 
            Bogalusa researchers found that dyslipidemia was associated with increased BMI.  
In the Bogalusa study, overweight children 5 to 17 years of age compared to normal 
weight children were 2.4 times as likely to have elevated levels of TC, 3.0 times more 
likely to have high LDL-C and 3.4 times as likely to have low HDL-C (Freedman, Dietz, 
Srinivasan, & Berenson, 1999).  NGHS researchers found strong associations between 
obesity and some dyslipidemia markers.  Obese females 9 to 18 years of age were 6.3 
times more likely to have HDL-C levels less than 50 mg/dl, and 3.3 times more likely to 
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have triglyceride levels at or greater than 130 mg/dl.  Obesity in this cohort was not 
significantly associated with elevated TC or elevated LDL-C levels.  Researchers 
adjusted for pubertal maturation as there was some association with lipids.  In this 
secondary analysis with adjustment for pubertal maturation, elevated LDL-C levels were 
significantly associated with obesity with OR = 3.0 (P = .01).  Total cholesterol remained 
not significantly associated (Thompson et al., 2007). 
           Holl et al. (2011) report on their findings from a large cross-sectional study 
conducted in Germany on subjects that were analyzed beginning in 2003.  The study 
purpose was to report on the effects of age, gender and obesity category on dyslipidemia 
components.  Participants included 29,711 overweight and obese subjects from the 
German, Austrian and Swiss APV registry (mean age 12.61 + 3.14) and the comparison 
group of 11,110 normal-weight subjects from the German Health Interview and 
Examination Survey for Children and Adolescents, KIGGS (mean age 9.8 + 4.7).  
Cutoffs for abnormal lipid values were based on American Heart Association 
recommendations, and with conversion from mmol/L to mg/dl were approximately TC 
greater than 200 mg/dl, HDL-C less than 35 mg/dl, LDL-C greater than 130 mg/dl, and 
triglycerides greater than 150 mg/dl.  Weight classifications used were different than the 
customary US standard, and were based on BMI-SDS values calculated with German 
normative data.  Youth were normal weight with BMI less than the 90
th
 percentile, 
overweight with BMI from the 90
th
 to 97
th
 percentile, obese with BMI between the 97
th
 to 
99.5
th
 percentile and extremely obese with BMI greater than the 99.5
th
 percentile.  
Although not a study on a US population, given the size of the cohort and significant 
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findings which are especially pertinent to the analysis section of this thesis, it is worthy of 
inclusion in this review.   
           As BMI categories increased, the prevalence of hypertriglyceridemia and reduced 
HDL-C increased rapidly.  A weaker relationship was present for LDL-C and TC, 
however still with high significance (p<0.0001).  Holl et al. (2011) reported at least one 
abnormal lipid value was found in 13.4% of normal-weight subjects, 24.3% of 
overweight patients, 27.9% of obese subjects and 31.9% in the extremely obese group 
(p<0.0001).  Multiple logistic regression analysis with age and gender as covariates in 
addition to BMI categories resulted in significant relative risk (RR) increases according 
to BMI category increases.  The RRs in comparison to normal weight subjects were as 
follows: for reduced HDL-C 1.52 (1.24-1.86) in overweight subjects to 4.39 (2.89-3.97) 
in extremely obese subjects, for elevated triglycerides 3.21 (1.18-8.75) in overweight 
subjects to 4.86 (1.79-13.18) in extremely obese subjects, for LDL-C the RR increased to 
1.94 (1.76-2.14) and for TC to 1.43 (1.31-1.57).  If the criterion of at least one abnormal 
lipid component was applied the RRs were as follows:  2.07 (1.87-2.28) for overweight 
subjects, 2.49 (2.33-2.67) for obese subjects and 3.02 (2.83-3.24) for extremely obese 
subjects (Holl et al., 2011).                 
2.8 Lipid Profile Statistics for US Youth 
           In an effort to present data that is more relevant to the state of current US youth 
lipid levels, this review will focus on recent studies that used data from the National 
Health and Nutrition Examination Survey (NHANES).  NHANES conducted by the 
CDC’s National Center for Health Statistics is a population based survey that examines 
nationally representative samples of the US non-institutionalized civilian population.  
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Data from NHANES is used to produce national estimates of US health and nutrition 
status.  Previous National Health and Nutrition Examination Survey (NHANES) studies 
have found prevalence of dyslipidemias in children and adolescents of approximately 
10% for TC, 26% for triglycerides, 6.6% for LDL-C and 19% for HDL-C (Ford, Li, 
Zhao, & Mokdad, 2009; Johnson et al., 2009; Li et al., 2010).  
           Li and colleagues (2010) compared statistics from a large national insurance 
claims database and NHANES 1999-2004 survey data.  In analysis of data from the 
NHANES cohort an estimated 7.4 million children out of 30 million US children 
(weighted frequency with fasting weights, unweighted n=585) had laboratory-defined 
dyslipidemia.  Laboratory defined dyslipidemia was identified by subjects having at least 
one abnormal lipid measure regardless of fasting status.  The dyslipidemic measurements 
were as follows: TC >200 mg/dl, HDL-C < 35 mg/dl, LDL-C > 130 mg/dl, Triglycerides 
> 130 mg/dl, Apolipoprotein A-I, (Apo-A) < 110 mg/dl, or Apolipoprotein B (Apo-B) > 
100 mg/dl.   With application of mobile examination center (MEC) and fasting weights 
this yielded a prevalence of approximately 19.9% (95% CI: 18.3-21.6) to 23.9% (95% 
CI: 21.60-26.27) respectively.  
           Children from 10 to 18 years of age with laboratory defined dyslipidemia were 
defined from the Integrated Healthcare Information Services (IHCIS) database for the 
years from 2003-2006.  The IHCIS database contained 273,064 children with at least one 
laboratory lipid value.  Of these children 22.9% (n=62451) had laboratory defined 
dyslipidemia.  A comparison cohort of 10 to 18 year old children was derived from 
NHANES survey years 1999-2004.  Prevalence for the IHCIS and NHANES cohorts 
were similar for triglycerides at 13.2% and 14.2% respectively.  Although prevalence of 
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overall dyslipidemia was similar, the prevalence for TC, HDL-C and LDL-C was lower 
in the IHCIS cohort (TC 9.6% vs. 7.7%, HDL-C 6.7% vs. 4.1%, and LDL-C 7.2% vs. 
3.2%).  Several theories for this were suggested by the researchers, such as insured status, 
health status, interventions and selection bias (Li et al., 2010).   
           The occurrence of dyslipidemias differed by age and gender amongst the two 
cohorts.  In the NHANES cohort 10 to11 year old boys displayed the highest prevalence 
(58%) of TC compared to 16-18 year old boys with the lowest prevalence (27%).  
Whereas TC prevalence for girls in the NHANES group was 45% in the 12 to 13 year old 
group and increased to 63% in the 16 to 18 year old girls.  The same trends were seen in 
the IHCIS cohorts for boys and girls.   
            For HDL-C, age-related dyslipidemia was reversed, with 10 to 11 year old boys in 
the NHANES group at the lowest prevalence (24%) compared to 16 to 18 year boys with 
the highest prevalence (57%).  This same trend was found in the IHCIS cohort, with the 
boys steadily increasing prevalence of dyslipidemic HDL-C with age.  There were 
differences between the cohorts for girls with dyslipidemic HDL-C.  In the NHANES 
cohort, dyslipidemic HDL-C decreased as the girls increased in age, whereas in the 
IHCIS girl’s cohort this did not occur.   
           For dyslipidemic triglycerides no age-related changes were found in the NHANES 
groups, whereas in the IHCIS cohort boys demonstrated an age-related increase.  LDL-C 
dyslipidemias were highest in the NHANES 10 to 13 year old boys at 37% compared to 
prevalence of 23% in the 16 to 18 year group.  Smaller age-related increases were also 
found in the IHCIS boys.   Girls in both cohorts experienced age-related increases (J. Li 
et al., 2010).   
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           IHCIS cohort data shows a decrease in TC dyslipidemia prevalence in the 12 to 13 
year old female group and 14 to 15 year old male group which then begins to rebound 
with increasing age.  This same trend occurs for LDL-C.  Detailed data on the NHANES 
cohort was not available for comparison.  This change in dyslipidemic TC and LDL-C 
prevalence at pubertal ages is consistent with other reported research where TC and LDL-
C levels decreased by 10 to 20% during puberty (Berenson, Srinivasan, Cresanta, Foster, 
& Webber, 1981; Kwiterovich et al., 1997).   
           Hickman et al. (1998) report on lipid distributions of NHANES data (1988-1994) 
which demonstrate similar trends for TC and HDL-C.  Children in the 9 to 11 year old 
group had the highest mean TC values (171 mg/dl).  Females had higher mean TC (167 
mg/dl) than males (163 mg/dl).  Among racial groups non-Hispanic blacks had 
significantly higher mean TC values (170 mg/dl) than non-Hispanic whites (164 mg/dl) 
or Mexican Americans (164 mg/dl).   Consistent with research on pubertal changes, boys 
mean TC levels were significantly less in the 12 to 15 year old group compared to boys 9 
to 11 years of age (P < 0.0001).  Hickman and colleagues report that mean TC levels 
among adolescents decreased by 7 mg/dl (P<0.0001) from 1966 to 1994.  This same 
trend had previously been reported in adults and is believed to have contributed to the 
decrease in mortality from CHD during the same period of time.   
           HDL-C levels were relatively constant across all age groups, except that boys 
mean HDL-C levels decreased significantly from the 9 to 11 age group to the 12 to 15 
year old group (P < 0.0001).  Overall, the means for HDL-C were similar for both sexes.  
Although in females the mean steadily increased with age, whereas in boys the mean was 
highest in the 9 to 10 year old group then steadily decreased.  Non-Hispanic blacks had 
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the highest mean HDL-C levels (55 male, 56 female) compared to non-Hispanic whites 
(48 male, 50 female) and Mexican Americans (51 male, 52 female).    
           The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk 
Reduction in Children and Adolescents include in their report that differences exist 
according to race and ethnicity according to geography and that these differences could 
be explained in part by socioeconomic status.  However, the Expert Panel also points out 
“that no group in the U.S. is without a significant prevalence of risk” (Kavey, Simons-
Morton, & de Jesus, 2011, p. S4).  Several longitudinal cohort studies have included 
biracial populations, but longitudinal studies that include Hispanic, Asian and Native 
American youth are lacking.   The Expert Panel acknowledges that differences exist in 
risk factor prevalence according to gender and race and that low socioeconomic status 
alone confers substantial risk.  However, the “evidence is not adequate” for the Expert 
Panel to make recommendations specific to racial or ethnic groups or socioeconomic 
status (Kavey et al., 2011, p. S4). 
2.9 Reliability of BMI at 85
th
 percentile as a Risk Factor 
           As previously described, a number of prospective studies have reported tracking of 
lipid levels from childhood into adulthood.  These studies have found that youth to adult 
levels correlate in the range of 0.4 (Daniels et al., 2011).  However, Magnussen et al. 
(2008) report on the instability of the classification of blood lipid levels in youth, to 
predict dyslipidemias in adults.  The results of their study show that 60% of youth who 
were identified with high risk LDL cholesterol levels did not have abnormal levels as 
adults and that most adults who developed low HDL-C did not have dyslipidemic HDL-C 
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as youth.  These findings contribute to the uncertainty surrounding the approach to and 
utility of screening for pediatric dyslipidemias (Magnussen et al., 2011, p. 68).   
           There is a volume of research that has examined the relationship between 
adiposity status and CVD risk factors in youth and which demonstrate positive 
correlations.  However studies are lacking which assess relationships with dyslipidemia 
and BMI at the 85th percentile or greater, the AAP screening criteria in youth.  The 
majority of research on US children has examined the relationship of obese, not 
overweight children and atherosclerosis development through pathology studies, sub-
clinical measures or lipid levels.  There are a number of international studies that have 
found positive associations between increasing levels of adiposity and more severe 
dyslipidemias (Flechtner-Mors et al., 2011; Katzmarzyk, Tremblay, Perusse, Despres, & 
Bouchard, 2003; Kim Soh Ye, Hong Kyung Hee, Jang Ki Hyo, Kang Soon Ah, & Choue 
Ryo Won, 2005; Takada et al., 1998; Zhai et al., 2004).  These studies however, are not 
readily generalized to the US pediatric population because many studies were conducted 
in Asian populations whose diets are often dissimilar to western foods and because they 
used different classification systems for childhood obesity making them difficult to 
compare (Cole, Bellizzi, Flegal, & Dietz, 2000).   
           In a more recent US study Lamb, Ogden, Carroll, Lacher, and Flegal (2011), 
analyzed National Health and Nutrition Examination Survey data (1999-2004) for 
associations between childhood adiposity and lipid levels.  However, due to concern 
about the accuracy of BMI as an adiposity measure, researchers instead measured body 
fat percentage by dual-energy X-ray absorptiometry.  A recent study by Lee and 
colleagues (2009) found BMI did not perform well in detecting youth with elevated TC 
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or LDL-C levels and called into question the current screening recommendations.  The 
study population was a NHANES cohort from 1999-2004 survey years.  Children 3 to 18 
years of old were evaluated for TC and HDL-C levels and 12 to 18 years of age for LDL-
C and triglycerides.  The researchers used receiver operating characteristic (ROC) curves 
to evaluate the performance of specific BMI percentiles in predicting dyslipidemias.  
ROC analysis for BMIs at the 85
th
 percentile produced area under the curve values of 
0.60 for TC, 0.63 for LDL-C, 0.69 for HDL-C and 0.72 for triglycerides. 
           Lee et al. (2009) also calculated sensitivity, specificity, positive predictive values 
(PPVs), and negative predictive values (NPVs) for each lipid factor at different BMI 
percentile thresholds.  BMI at the 85
th
 percentile as a threshold screening test for TC 
dyslipidemia resulted in sensitivity and specificity levels of 53% and 63% respectively, 
PPV (14%) and NPV (93%).   BMI at the 85th percentile as a screening test for HDL-C 
dyslipidemia resulted in sensitivity and specificity of 63% and 65% respectively, PPV 
(11%) and NPV (97%).   
           National expert guidelines recommend BMI at the 85th percentile as the screening 
threshold for children and adolescents at risk for dyslipidemia, although research to 
support this cutpoint is unclear.  Even the Expert Panel Guidelines, with their extensive 
research review, do not include studies on this specific relationship.  The association of 
childhood obesity and cardiovascular disease is well documented.  However, additional 
research is needed on the relationship of overweight youth and dyslipidemia prevalence.  
Cardiovascular disease primary prevention goals for youth address two main areas: 
prevention of the development of risk factors and prevention to recognize and manage 
youth at risk due to identified risk factors.  National expert bodies have developed 
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guidelines which delineate children at risk who should receive targeted screening.  
Screening guidelines include recommendations to perform serum lipid evaluations on 
overweight children.  The objective of this thesis is to add to the body of knowledge 
concerning the relationship between youth with BMIs at the 85
th
 percentile or greater and 
dyslipidemias of TC, HDL-C and non-HDL-C.
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CHAPTER III 
METHODOLOGY 
3.1 Subjects 
           The data source for this study is the National Health and Nutrition Examination 
Survey (NHANES) 2007-2008 and 2009-2010 survey years.  NHANES is conducted 
through the National Center for Health Statistics of the Centers for Disease Control and 
Prevention (CDC).  The survey program began in the 1960s and since has evolved into a 
continuous program that is conducted every two years.  NHANES is highly regarded as 
the most comprehensive study of the health and nutrition status of adults and children in 
the US.  Strict confidentiality is maintained throughout the process.  De-identified survey 
data are publicly available through the NHANES website.  The survey combines 
interview and physical examination data from a nationally representative sample of 
approximately 5,000 persons each year.  The NHANES interview is conducted in the 
sample person’s home and includes demographic, socioeconomic, nutrition and health-
related questions.  The examination section is conducted in the mobile examination 
center (MEC) by physicians and highly trained medical personnel.  The examination 
includes medical, dental, and physiological measurements and laboratory tests (Centers 
for Disease Control and Prevention, 2012). 
           NHANES is conducted according to strict protocol and informed consent is 
obtained from participants.  For each survey cycle, NHANES undergoes National Center 
for Health Statistics (NCHS) Research Ethics Review Board Approval.  Manuals 
developed for interviewer and examiner training are available for public viewing on the
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NHANES website.  These manuals contain exact details on all policies, procedures and 
standards for conducting NHANES survey components (Centers for Disease Control and 
Prevention, 2011). Georgia State University Institutional Review Board approval was 
granted for this study under Protocol Type H12278, Exempt Review, Category 4.         
           NHANES uses a complex, multistage, probability sampling design in an effort to 
select participants that are representative of the civilian, non-institutionalized US 
population.  Certain subgroups are oversampled in order to produce reliable statistics.  
NHANES oversamples the elderly, Hispanics, African-Americans and low income 
persons.  In the first stage primary sampling units (PSUs) are selected, which are mostly 
single counties or less often groups of contiguous counties.  These PSUs are selected 
from strata defined by geography and proportions of minority populations.  In the second 
stage, PSUs are divided into segments such as city blocks.  In stage 3, households are 
randomly selected from each segment.  In stage 4, individuals are randomly chosen to 
participate from all persons residing in the household, which results in approximately 1.6 
persons per household.  Each sample person is assigned a sample weight.  This weight is 
used to produce an unbiased national estimate (Centers for Disease Control and 
Prevention, n.d.). 
           The original 2007-2008 survey consisted of 10149 sample persons and the 2009-
2010 survey had 10537 sample persons.  Complete body measurements were available on 
8088 sample persons from the 2007-2008 survey and 8608 sample persons from the 
2009-2010 survey.  Of these 7387 and 7846 sample persons in the 2007-2008 and 2009-
2010 respective surveys had TC and HDL-C laboratory values.  In these survey years, 
total cholesterol and HDL-C measurements were conducted on participants beginning at 
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6 years of age.  The subset for the present study consists of males and females 6 through 
18 years of age who had complete body measurements, TC and HDL-C measurements.  
The final data set of combined survey cycles contains 3888 participants of which 2016 
are male and 1872 are female.      
           Beginning in 2007 NHANES employed a new sampling methodology, whereby 
other Hispanics were oversampled, not just Mexican-Americans.  For example in the 
2005-2006 cycle other Hispanics comprised 3.3% of the unweighted sample size, 
whereas in 2007-2008 this unweighted sample consisted of 11.7% and 10.8% in 2009-
2010.  The like percentages for Mexican-Americans were as follows:  2005-2006 
(27.5%), 2007-2008 (21.1%) and 2009-1010 (22.5%).  The non-Hispanic black 
unweighted sample decreased from 26.3% in 2005-2006, to 21.9% in 2007-2008 and 
finally 18.6% in 2009-2010.  The non-Hispanic white and other race/ethnicity categories 
both had small increases overall.  Beginning with the 2007 year survey, changes in the 
age domains led to a decrease in the number of participants under 20 years old and an 
increase in the number of participants 40 years of age or greater.  Also beginning with the 
2007-2008 survey, pregnant women were no longer oversampled. 
           NHANES has been in existence for over 50 years and is renowned as a 
comprehensive, national data source for health research interests.  NHANES is highly 
regarded for adhering to rigorous sampling and data collection processes.  Although the 
researchers are highly trained and protocols are followed, there is always the possibility 
for human and/or technical error.  For NHANES in general, selection bias can be present 
as subjects are invited to participate and are paid for their participation.  As a result, the 
cohort of subjects who elect to participate may differ from those that do not.  In addition, 
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participants do not have to complete all components of the survey.  For example 
questions may not be answered and laboratory tests refused.   The interview component 
relies on self-reported information thus lending itself to error with recall or information 
bias.  There is limitation of race/ethnicity groups.  The sampling methodology of 
NHANES produces three main groups, Mexican-American, non-Hispanic black and non-
Hispanic white.  The 2007 sampling change has enlarged the other Hispanic sample 
group, which allows for stronger analysis of this group.  There is no distinct Asian group.   
           Parameters for exam, laboratory analysis and interview questions vary especially 
by age.  For example TC and HDL-C testing begins at age 6 years, but triglyceride and 
LDL-C testing begins at age 12 years and is restricted to fasting individuals.  Since all 
participants may not adhere to fasting instructions or falsely report their fasting time, this 
could affect the reliability of these lab values.  In addition, because a fasting state was 
required, noncompliance would further decrease the number of participants who would 
be eligible for this component of the exam.  In another example, history of hypertension 
was initially considered for inclusion in the present study, as a possible confounder, but 
was not, because blood pressure interview questions in NHANES are only asked of 
participants who are at least 16 years of age.  
3.2 Definition of Terms 
           The variables used in this study are gender, age, race/ethnicity, income, cotinine, 
BMI percentile, TC, HDL-C and non-HDL-C.  Age is measured in months at the time of 
MEC.  The study cohort includes youth from 72 through 227 months of age.  The lower 
threshold of 72 months was selected because this is the minimum age for NHANES 
participants to receive TC and HDL-C laboratory analysis.  The first age category is 6 to 
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8 years of age.  The second age category is 9 to 11 years, because this group is 
recommended to receive universal screening.  The third category is 12 to 15 years of age, 
in an effort to capture the pubertal years.  The last age category is 16 to 18 years.  The 
selection of 18 year olds as the upper limit was somewhat arbitrary.  The present study is 
on children and adolescents.  The literature review revealed an assortment of ages studied 
including adolescents 18 and 19 years of age.  Universal lipid screening is recommended 
for persons 18 to 21 years of age and with the guidelines published in December 2011, 
the age for universal screening was lowered to 17 years, hence a 17 or 18 year old could 
receive lipid screening without having other risk factors.  All other age categories 
consisted of at least three progressive age years.  Including 17 and 18 year olds in the 
oldest age category enabled this group to have three progressive years and more closely 
resemble the other groups in size.   
           NHANES uses five race/ethnicity categories: non-Hispanic white, non-Hispanic 
black, Mexican-American, other Hispanic and other.  The present study is comprised of 
four race/ethnicity categories.  Three categories are comprised of the same NHANES 
subjects for non-Hispanic white, non-Hispanic black, and Mexican-American.  The 
fourth race/ethnicity category is a merged “other” category derived from the NHANES 
other Hispanic and other groups.  This fourth merged other category resulted in a subset 
of 723 persons out of a total sample group of 3888. 
           The total household income variable was used as a socioeconomic indicator 
variable.  Income was divided into five categories by merging NHANES categories.  The 
resulting five income levels ranged from very low at $0 to $19,999 to high at $100,000 or 
greater.   
36 
 
 
    
           Tobacco exposure was accounted for by including the laboratory value for 
cotinine.  According to CDC literature, cotinine levels less than 1 ng/ml indicate non-
tobacco exposure.  A person with cotinine levels ranging from 1 to 10 ng/ml is 
environmentally exposed and levels above 10 ng/ml represent tobacco use.   
           As the focus of the present study is to analyze associations between BMI 
categories used in the current guidelines and dyslipidemia, it was imperative to use the 
same BMI categories.  BMI percentile rankings are categorized according to CDC 2000 
pediatric growth chart rankings for obese, overweight, normal and underweight children 
and adolescents.  The 85
th
 to 94
th
 percentile is the overweight category and threshold for 
lipid screening in youth.  Children with BMI percentiles at the 95
th
 percentile or greater 
are considered obese.  Normal or healthy weight children range in the 5
th
 to 84
th
 BMI 
percentile and underweight children are less than the 5
th
 BMI percentile. 
           Three lipid values are used in this analysis, total cholesterol (TC), high-density 
lipid cholesterol (HDL-C) and non-high-density lipid cholesterol (non-HDL-C).  For 
categorical analysis values are categorized into two variables.  Total cholesterol less than 
200 mg/dl is ‘Acceptable to Borderline’.  Total cholesterol at or greater than 200 mg/dl is 
‘High’.  With HDL-C, the lower values are abnormal, thus a value less than 40 mg/dl is 
‘Low’ and values at or greater than 40 mg/dl are ‘Acceptable to Borderline-Low’.  Non-
HDL-C is not included in NHANES surveys, but is easily calculated by subtracting HDL-
C from TC.  Non-HDL-C is ‘High’ with values at or greater than 145 mg/dl and 
‘Acceptable to Borderline-High’ if less than 145 mg/dl.  The definitions used in this 
study for TC, HDL-C and non-HDL-C are consistent with expert panel guidelines from 
major national organizations (Kavey, Simons-Morton, & de Jesus, 2011). 
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3.3 Statistical Analysis 
           SAS 9.2 was used for all analysis in this study (SAS Institute Inc., 2012).  Survey 
documentation for both NHANES two year cycles 2007-2008 and 2009-2010 were 
thoroughly reviewed to select needed variables.  Data from two 2-year cycles was 
combined in order to produce estimates with greater statistical reliability.  All of the 
selected variables from both 2-year cycles have the same names and definitions hence 
data files were appended directly.  The appended dataset was sorted by sequence number 
and Demographic, Examination and Laboratory data files were merged. 
           Triglyceride and LDL-C data were considered for inclusion in this study.  
However, in NHANES triglycerides and LDL-C lab values are only computed on 
participants who are fasting and at least 12 years of age and older.  As a result 
approximately 76% of the study sample did not have these lab values.  Non-HDL-C is 
gaining recognition as an important risk marker and could be calculated for inclusion in 
this study.  Non-HDL-C includes LDL-C and triglycerides, thus considering the 
possibility and benefits of including Non-HDL-C in the present study and deficit of a 
smaller sample size for triglycerides and LDL-C, triglycerides and LDL-C were not 
included in the present study.   
           Diabetes history was considered, but not included as a covariate.  In NHANES, the 
interview question for diabetes history and laboratory exam for glycohemogloblin, a 
diabetes indicator, are implemented in subjects beginning at 12 years of age.  Thus like 
triglycerides and LDL-C mentioned above, inclusion of this covariate would substantially 
reduce the sample size for this study.  It was also noted that there were only 22 positive 
responses from subjects in the sample indicating they had a history of diabetes.  
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Considering the factors of low diabetes prevalence and that inclusion would necessitate a 
substantial reduction in sample size, the decision was made not to include a diabetes 
covariate.  Pregnancy history questions and laboratory pregnancy testing data are only 
available in NHANES on women beginning at 20 years of age, thus pregnant subjects are 
not accounted for in this study. 
           NHANES files were reviewed to check for skip patterns in regards to the variables 
selected and none were found.  Univariate analysis was conducted for continuous 
variables TC, HDL-C, LDL- C and triglycerides to check the distribution and identify 
outliers.  Although there were some outliers, no outliers were removed for this study, 
primarily because their impact was germane to the present study, i.e., extremely high TC 
or non-HDL-C or low HDL-C.  Multivariate regression analysis was conducted with and 
without the inclusion of one extremely low TC variable (TC = 66 mg/dl) and the results 
were effectively unchanged, hence this outlier was left in the study sample.  The variable 
for non-HDL-C was created.  The SAS program for CDC Growth Charts was conducted 
in order to add the BMI percentile variable to the dataset.  Data was recoded into 
categorical variables as described in Definition of Terms above.   
           Descriptive statistics of the study sample are shown in Tables 1, 2 and 3.  The 
independent-samples t-test is conducted to test equality between mean lipid values for 
males and females (Table 4).  The sample sizes for males (n=2016) and females (n=1872) 
are represented fairly evenly.  The large sample size n=3888 compensates for violations 
of normality assumption.  For all three lipid factors, the F value is small, but significant 
to reject equal variances, and both the Pooled (equal) and Satterthwaite (unequal) t-
statistics are not significant for mean differences.  Satterthwaite t-statistics are included in 
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Table 4.  Analysis of variance (ANOVA) was completed to examine mean differences of 
lipid values for all other categorical variables and results are presented in Tables 5, 6 and 
7.  Sensitivity, specificity, positive predictive value (PPV) and negative predictive value 
(NPV) of BMI percentile risk factor agreement with dyslipidemias were calculated for 
the entire sample and stratified by age category with results presented in Tables 8, 9 and 
10.  Because the focus of this study is the overweight category of children, in contrast to 
obese, only the overweight category children were included as positive tests.  For 
negative tests, only healthy weight children were included.   
 Simple logistic regression analyses were completed for each covariate and lipid 
factor and the results are presented in Table 11.  Multiple logistic regression was 
completed including all categorical independent variables for each lipid factor and the 
results are presented in Table 12.
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CHAPTER IV 
RESULTS 
4.1 Study Sample Demographics 
           There are 3888 subjects overall in this study sample who comprised the age range 
of 6 through 18 years and who had measures for BMI percentile, TC and HDL-C.  
Descriptive statistics for the covariates of gender, age, race ethnicity, income, cotinine 
levels and BMI percentages are presented in Tables 1, 2 and 3 for each lipid factor 
studied.  Males represent 52% (n= 2016) and females 48% (n= 1872).  The four age 
categories (6-8 years, 9-11 years, 12-15 years and 16-18 years) are fairly evenly divided.  
There are higher proportions of non-Hispanic whites (31%) and Mexican-Americans 
(28%) compared to Non-Hispanic blacks (22%) and other (19%) race ethnic groups.                        
Household income is categorized into five levels.  This subset of the study group is 
somewhat smaller at n=3625.  The low income group ($20,000 to $44,999) is the largest 
at 33%.  The moderately high income group ($75,000 to $99,999) is the smallest at 9%.  
The subset for cotinine level analysis is slightly smaller at n=3865.  Approximately 5% of 
the subset are tobacco users and 11% are environmentally exposed. 
           Twenty-two percent (n=840) of the sample is obese.  Overweight youth comprise 
17% of the study population (n=652).  Fifty-nine percent (n=2283) of the sample are a 
healthy weight and 3% (n=113) are underweight.  As depicted in Table 2 dyslipidemic 
HDL-C is the most prevalent abnormal lipid factor with 52% of obese children and 
adolescents at abnormal levels.  Although underweight youth have lower levels of 
dyslipidemia, they do not always have the lowest prevalence per lipid factor.  The lowest
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prevalence for dyslipidemias occurs for non-HDL-C in the underweight group (4%), but 
for TC and HDL-C the lowest prevalence is in the healthy weight group at 6% and 18% 
respectively.  Abnormality of lipid prevalence progressively increases as BMI percentile 
categories transition from healthy weight to obese for all three lipid factors.
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Table 1 
Total Cholesterol (TC) Values Descriptive Statistics of Study Sample 
 
Variables Acceptable to 
Borderline-High <200 
mg/dl 
High >=200 
mg/dl 
Total 
Gender (N=3888)    
Male 1851 (91.82%) 165 (8.18%) 2016 (51.85%) 
Female 1739 (92.90%) 133 (7.10%) 1872 (48.15%) 
Total 3590 (92.34%) 298 (7.66%) 3888 
    
Age (N=3888)    
6-8 years 844 (91.74%) 76 (8.26%) 920 (23.66%) 
9-11 years 916 (90.60%) 95 (9.40%) 1011 (26.00%) 
12-15 years 1038 (94.36%) 62 (5.64%) 1100 (28.29%) 
16-18 years 792 (92.42%) 65 (7.58%) 857 (22.04%) 
Total 3590 (92.34%) 298 (7.66%) 3888 
    
BMI Percentiles (N=3888)    
Underweight <5th Percentile 103 (91.15%) 10 (8.85%) 113 (2.91%) 
Healthy Weight 5th – 84th Percentile 2148 (94.09%) 135 (5.91%) 2283 (58.72%) 
Overweight 85th – 94th Percentile 593 (90.95%) 59 (9.05%) 652 (16.77%) 
Obese >=95th Percentile 746 (88.81%) 94 (11.19%) 840 (21.60%) 
Total 3590 (92.34%) 298 (7.66%) 3888  
    
Race Ethnicity (N=3888)    
Non-Hispanic white 1116 (92.69%) 88 (7.31%) 1204 (30.97%) 
Non-Hispanic black 804 (91.99%) 70 (8.01%) 874 (22.48%) 
Mexican-American 1012 (93.10%) 75 (6.90%) 1087 (27.96%) 
Other 658 (91.01%) 65 (8.99%) 723 (18.60%) 
Total 3590 (92.34%) 298 (7.66%) 3888 
    
Household Income (N=3625)    
$0 to $19,999 771 (92.56%) 62 (7.44%) 833 (22.98%) 
$20,000 to $44,999 1105 (91.78%) 99 (8.22%) 1204 (33.21%) 
$45,000 to $74,999 692 (93.01%) 52 (6.99%) 744 (20.52%) 
$75,000 to $99,999 303 (92.10%) 26 (7.90%) 329 (9.08%) 
$100,000+ 478 (92.82%) 37 (7.18%) 515 (14.21%) 
Total 3349 (92.39%) 276 (7.61%) 3625 
    
Cotinine Levels (N=3865)    
Non-Tobacco Exposure <1 ng/ml 3012 (92.42%) 247 (7.58%) 3259 (84.32%) 
Environmental Tobacco Exposure 1 
to 10 ng/ml 
386 (92.12%) 33 (7.88%) 419 (10.84%) 
Tobacco User >10 ng/ml 170 (90.91%) 17 (9.09%) 187 (4.84%) 
Total 3568 (92.32%) 297 (7.68%) 3865 
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Table 2 
High-Density Lipoprotein Cholesterol (HDL-C) Values Descriptive Statistics of Study Sample 
Variables Acceptable to 
Borderline-Low 
>=40 mg/dl 
Low  <40 mg/dl Total 
Gender (N=3888)    
Male 1446 (71.73%) 570 (28.27%) 2016 (51.85%) 
Female 1377 (73.56%) 495 (26.44%) 1872 (48.15%) 
Total 2823 (72.61%) 1065 (27.39%) 3888 
    
Age (N=3888)    
6-8 years 726 (78.91%) 194 (21.09%) 920 (23.66%) 
9-11 years 746 (73.79%) 265 (26.21%) 1011 (26.00%) 
12-15 years 787 (71.55%) 313 (28.45%) 1100 (28.29%) 
16-18 years 564 (65.81%) 293 (34.19%) 857 (22.04%) 
Total 2823 (72.61%) 1065 (27.39%) 3888 
    
BMI Percentiles (N=3888)    
Underweight <5th Percentile 92 (81.42%) 21 (18.58%) 113 (2.91%) 
Healthy Weight 5th – 84th Percentile 1875 (82.13%) 408 (17.87%) 2283 (58.72%) 
Overweight 85th – 94th Percentile 450 (69.02%) 202 (30.98%) 652 (16.77%) 
Obese >=95th Percentile 406 (48.33%) 434 (51.67%) 840 (21.60%) 
Total 2823 (72.61%) 1065 (27.39%) 3888 
    
Race Ethnicity (N=3888)    
Non-Hispanic white 851 (70.68%) 353 (29.32%) 1204 (30.97%) 
Non-Hispanic black 710 (81.24%) 164 (18.76%) 874 (22.48%) 
Mexican-American 747 (68.72%)  340 (31.28%) 1087 (27.96%) 
Other 515 (71.23%) 208 (28.77%) 723 (18.60%) 
Total 2823 (72.61%) 1065 (27.39%) 3888 
    
Household Income (N=3625)    
$0 to $19,999 584 (70.11%) 249 (29.89%) 833 (22.98%) 
$20,000 to $44,999 857 (71.18%) 347 (28.82%) 1204 (33.21%) 
$45,000 to $74,999 539 (72.45%) 205 (27.55%) 744 (20.52%) 
$75,000 to $99,999 248 (75.38%) 81 (24.62%) 329 (9.08%) 
$100,000+ 409 (79.42%) 106 (20.58%) 515 (14.21%) 
Total 2637 (72.74%) 988 (27.26%) 3625 
    
Cotinine Levels (N=3865)    
Non-Tobacco Exposure <1 ng/ml 2404 (73.76%) 855 (26.24%) 3259 (84.32%) 
Environmental Tobacco Exposure 1 
to 10 ng/ml 
295 (70.41%) 124 (29.59%) 419 (10.84%) 
Tobacco User >10 ng/ml 107 (57.22%) 80 (42.78%) 187 (4.84%) 
Total 2806 (72.60%) 1059 (27.40%) 3865 
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Table 3 
Non-High-Density Lipoprotein-Cholesterol (Non-HDL-C) Values Descriptive Statistics of Study 
Sample 
Variables Acceptable to 
Borderline-Low 
>=40 mg/dl 
Low  <40 mg/dl Total 
Gender (N=3888)    
Male 1816 (90.08%) 200 (9.92%) 2016 (51.85%) 
Female 1717 (91.72%) 155 (8.28%) 1872 (48.15%) 
Total 3533 (90.87%) 355 (9.13%) 3888 
    
Age (N=3888)    
6-8 years 856 (93.04%) 64 (6.96%) 920 (23.66%) 
9-11 years 906 (89.61%) 105 (10.39%) 1011 (26.00%) 
12-15 years 1012 (92.00%) 88 (8.00%) 1100 (28.29%) 
16-18 years 759 (88.56%) 98 (11.44%) 857 (22.04%) 
Total 3533 (90.87%) 355 (9.13%) 3888 
    
BMI Percentiles (N=3888)    
Underweight <5th Percentile 108 (95.58%) 5 (4.42%) 113 (2.91%) 
Healthy Weight 5th – 84th Percentile 2160 (94.61%) 123 (5.39%) 2283 (58.72%) 
Overweight 85th – 94th Percentile 582 (89.26%) 70 (10.74%) 652 (16.77%) 
Obese >=95th Percentile 683 (81.31%) 157 (18.69%) 840 (21.60%) 
Total 3533 (90.87%) 355 (9.13%) 3888 
    
Race Ethnicity (N=3888)     
Non-Hispanic white 1073 (89.12%) 131 (10.88%) 1204 (30.97%) 
Non-Hispanic black 816 (93.36%) 58 (6.64%) 874 (22.48%) 
Mexican-American 989 (90.98%) 98 (9.02%) 1087 (27.96%) 
Other 655 (90.59%) 68 (9.41%) 723 (18.60%) 
Total 3533 (90.87%) 355 (9.13%) 3888 
    
Household Income (N=3625)    
$0 to $19,999 752 (90.28%) 81 (9.72%) 833 (22.98%) 
$20,000 to $44,999 1080 (89.70%) 124 (10.30%) 1204 (33.21%) 
$45,000 to $74,999 686 (92.20%) 58 (7.80%) 744 (20.52%) 
$75,000 to $99,999 303 (92.10%) 26 (7.90%) 329 (9.08%) 
$100,000+ 474 (92.04%) 41 (7.96%) 515 (14.21%) 
Total 3295 (90.90%) 330 (9.10%) 3625 
    
Cotinine Levels (N=3865)    
Non-Tobacco Exposure <1 ng/ml 2972 (91.19%) 287 (8.81%) 3259 (84.32%) 
Environmental Tobacco Exposure 1 
to 10 ng/ml 
381 (90.93%) 38 (9.07%) 419 (10.84%) 
Tobacco User >10 ng/ml 158 (84.49%) 29 (15.51%) 187 (4.84%) 
Total 3511 (90.84%) 354 (9.16%) 3865 
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           Table 4 depicts the Independent-Samples t-test analysis to compare mean values of 
the three lipid factors studied among males and females.  There are no significant 
differences in the mean values for any of the three lipids between males and females.   
Table 4 
Lipid Factors Independent-Samples t-Test (N=3888) 
 
Lipid Variable Mean (95% CI) t Value Pr > [t] 
Total Cholesterol  -1.27 0.2037 
Male 158.7 (157.5, 159.9)   
Female   159.8 (158.6, 161.0)   
    
HDL-C  -0.26 0.7975 
Male  52.6 (52.0, 53.2)   
Female  52.7 (52.1, 53.2)   
    
Non-HDL-C  -1.17 0.2430 
Male  106.1 (104.9, 107.4)   
Female  107.1 (106.0, 108.3)   
    
Male (N=2016) 
Female (N=1872) 
 
           Tables 5, 6 and 7 are an ANOVA analysis to examine the differences of the mean 
lipid values for each multi-categorical independent variable.  ANOVA analysis for total 
cholesterol mean values is presented in Table 5.  There are significant mean differences 
of TC values according to age and BMI percentile categories.  Children 6 to 8 years of 
age have mean TC values approximately 6 mg/dl higher than youth in the 12 to 15 year 
age group.  Youth in the 9 to 11 year old group have mean levels of TC significantly 
higher than both older groups.  The mean TC value for healthy weight children is 
approximately 3 mg/dl lower than overweight children and approximately 5 mg/dl lower 
than obese youth.     
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Table 5 
Total Cholesterol (TC) Analysis of Variance 
 
Variable Categorical Comparisons Difference Between Means 
(95% CI) 
F Value Pr > F 
BMI Percentiles (N=3888)  8.91 <.0001 
Healthy Weight – Underweight -2.7069 (-9.5156, 4.1018)   
Healthy Weight – Overweight -3.4511 (-6.5883, -0.3139)***   
Healthy Weight – Obese -5.4068 (-8.2579, -2.5558)***   
Overweight – Underweight 0.7442 (-6.4549, 7.9433)   
Overweight – Obese -1.9557 (-5.6432, 1.7318)   
Obese – Underweight 2.6999 (-4.3792, 9.7790)   
    
Age (N=3888)  13.70 <.0001 
Age 6-8 years - Age 9-11 years -1.159 (-4.373, 2.054)   
Age 6-8 years - Age 12-15 years 5.891 (2.741, 9.042)***   
Age 6-8 years - Age 16-18 years 2.770 (-0.578, 6.118)   
Age 9-11 years - Age 12-15 years 7.051 (3.978, 10.123)***   
Age 9-11 years - Age 16-18 years 3.930 (0.655, 7.204)***   
Age 12-15 years - Age 16-18 years -3.121 (-6.334, -0.092)   
    
Race Ethnicity (N=3888)  1.07 0.3586 
Non-Hispanic white - Non-Hispanic black 0.324 (-2.825, 3.473)   
Non-Hispanic white - Mexican-American 1.197 (-1.768, 4.162)   
Non-Hispanic white – Other -1.145 (-4.480, 2.189)   
Non-Hispanic black - Mexican-American 0.873 (-2.346, 4.093)   
Non-Hispanic black – Other -1.469 (-5.031, 2.093)   
Mexican-American – Other -2.342 (-5.743, 1.059)   
    
Household Income (N=3625)  1.81 0.1246 
0 to $19,999 - $20,000 to $44,999 -2.333 (-5.722, 1.056)   
0 to $19,999 - $45,000 to $74,999 0.280 (-3.513, 4.074)   
0 to $19,999 - $75,000 to $99,999 -2.813 (-7.709, 2.084)   
0 to $19,999 - $100,000+ -1.916 (-6.132, 2.300)   
$20,000 to $44,999 - $45,000 to $74,999 2.613 (-0.894, 6.120)   
$20,000 to $44,999 - $75,000 to $99,999 -0.480 (-5.158, 4.199)   
$20,000 to $44,999 - $100,000+ 0.417 (-3.543 4.377)   
$45,000 to $74,999 – $75,000 to $99,999 -3.093 (-8.072, 1.886)   
$45,000 to $74,999 - $100,000+ -2.196 (-6.507, 2.115)   
$75,000 to $99,999 - $100,000+ 0.897 (-4.411, 6.204)   
    
Cotinine Levels (N=3865)  2.37 0.0937 
Non-Tobacco –Environmental Tobacco 1.7298 (-1.6272, 5.0867)   
Non-Tobacco -  Tobacco User 3.9416 (-0.9223, 8.8055)   
Environmental Tobacco – Tobacco User 2.2118 (-3.4766, 7.9003)   
    
***comparisons significant at the 0.05 level  
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           As depicted in Table 6, all five multi-categorical covariates examined for HDL-C 
mean differences have significant findings as described to follow.  Six to 8 year olds have 
higher mean HDL-C values than 12 to 18 year olds.  HDL-C mean values of 16 to 18 
year old adolescents are lower than youth 9 through 15 years of age.  There are 
significant differences in HDL-C mean values according to participant BMI percentiles, 
which paralleled increasing weight categories.  The most extreme is a decrease of 12 
mg/dl in obese compared to underweight youth.  The mean HDL-C of non-Hispanic 
whites and Mexican-Americans is approximately 5 mg/dl lower than non-Hispanic 
blacks.  The other race ethnicity group has a mean HDL-C value that is approximately 4 
mg/dl lower than non-Hispanic blacks.  Study youth in households at the lowest income 
have lower HDL-C mean levels when compared to study participants in the higher 
income groups.  The mean values of HDL-C are 4 mg/dl lower in tobacco users 
compared to those environmentally exposed to tobacco, and 5 mg/dl lower in tobacco 
users in comparison to non-tobacco users.   
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Table 6 
High-Density Lipoprotein Cholesterol (HDL-C) Analysis of Variance 
 
Variable Categorical Comparisons Difference Between Means 
(95% CI) 
F Value Pr > F 
BMI Percentiles (N=3888)  161.13 <.0001 
Healthy Weight – Underweight -2.0747 (-5.0581, 0.9088)   
Healthy Weight – Overweight 4.8203 (3.4456, 6.1950)***   
Healthy Weight – Obese 10.2800 (9.0308, 11.5293)***   
Overweight – Underweight -6.8950 (-10.0495, -3.7404)***   
Overweight – Obese 5.4598 (3.8439, 7.0756)***   
Obese - Underweight -12.3547 (-15.4567, -9.2527)***   
    
Age (N=3888)  16.41 <.0001 
Age 6-8 years - Age 9-11 years -1.2487 (-0.2376, 2.7351)   
Age 6-8 years - Age 12-15 years 2.4499 (0.9924, 3.9073)***   
Age 6-8 years - Age 16-18 years 4.0192 (2.4705, 5.5679)***   
Age 9-11 years - Age 12-15 years 1.2012 (-0.2201, 2.6224)   
Age 9-11 years - Age 16-18 years 2.7705 (1.2558, 4.2852)***   
Age 12-15 years - Age 16-18 years 1.5693 (0.0830, 3.0556)***   
    
Race Ethnicity (N=3888)  34.30 <.0001 
Non-Hispanic white - Non-Hispanic black -4.9946 (-6.4345, -3.5548)***   
Non-Hispanic white - Mexican-American 0.1752 (-1.1804, 1.5309)   
Non-Hispanic white - Other -1.1225 (-2.6470, 0.4019)   
Non-Hispanic black - Mexican-American 5.1698 (3.6978, 6.6419)***   
Non-Hispanic black - Other 3.8721 (2.2432, 5.5010)***   
Mexican-American - Other -1.2978 (-2.8527, 0.2572)   
    
Household Income (N=3625)  3.03 0.0166 
0 to $19,999 - $20,000 to $44,999 -1.1062 (-2.6724, 0.4599)   
0 to $19,999 - $45,000 to $74,999 -1.2174 (-2.9704, 0.5355)   
0 to $19,999 - $75,000 to $99,999 -2.2689 (-4.5316, 0.0061)***   
0 to $19,999 - $100,000+ -2.0847 (-4.0327, -0.1368)***   
$20,000 to $44,999 - $45,000 to $74,999 -0.1112 (-1.7317, 1.5094)   
$20,000 to $44,999 - $75,000 to $99,999 -1.1626 (-3.3244, 0.9992)   
$20,000 to $44,999 - $100,000+ -0.9785 (-2.8082, 0.8512)   
$45,000 to $74,999 – $75,000 to $99,999 -1.0514 (-3.3522, 1.2494)   
$45,000 to $74,999 - $100,000+ -0.8673 (-2.8593, 1.1247)   
$75,000 to $99,999 - $100,000+ 0.1841 (-2.2685, 2.6367)   
    
Cotinine Levels (N=3865)  15.18 <.0001 
Non-Tobacco –Environmental Tobacco 1.1539 (-0.3932, 2.7010)   
Non-Tobacco -  Tobacco User 5.1123 (2.8706, 7.3539)***   
Environmental Tobacco – Tobacco User 3.9583 (1.3367, 6.5800)***   
    
***comparisons significant at the 0.05 level 
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           ANOVA analysis for non-HDL-C value mean differences is presented in Table 7.  
Significant findings are in the age, BMI percentile and race ethnicity groups as follows.  
Children 12 to 15 years old have lower non-HDL-C mean values in comparison to all the 
other age groups.  Non-HDL-C mean values are progressively higher in parallel to 
increasing BMI percentile groups for all comparisons, except the underweight to healthy 
weight comparison which lacks significance.  Non-Hispanic black participants have mean 
values approximately 4 to 5 mg/dl lower than all other race ethnicity study groups. 
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Table 7 
Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Analysis of Variance 
Variable Categorical Comparisons Difference Between Means  
(95% CI) 
F Value Pr > F 
BMI Percentiles (N=3888)  77.10 <.0001 
Healthy Weight – Underweight -0.6322 (-7.1869, 5.9225)   
Healthy Weight – Overweight -8.2714 (-11.2916, -5.2512)***   
Healthy Weight – Obese -15.6869 (-18.4316, -12.9421)***   
Overweight – Underweight 7.6392 (0.7086, 14.5698)***   
Overweight – Obese -7.4155 (-10.9654, -3.8655)***   
Obese – Underweight 15.0546 (8.2396, 21.8697)***   
    
Age (N=3888)  9.14 <.0001 
Age 6-8 years - Age 9-11 years -2.408 (-5.587, 0.771)   
Age 6-8 years - Age 12-15 years 3.441 (0.324, 6.558)***   
Age 6-8 years - Age 16-18 years -1.249 (-4.561, 2.063)   
Age 9-11 years - Age 12-15 years 5.849 (2.810, 8.889)***   
Age 9-11 years - Age 16-18 years 1.159 (-2.080, 4.399)   
Age 12-15 years - Age 16-18 years -4.690 (-7.869, -1.511)***   
    
Race Ethnicity (N=3888)  7.85 <.0001 
Non-Hispanic white - Non-Hispanic black 5.318 (2.216, 8.420)***   
Non-Hispanic white - Mexican-American 1.022 (-1.899, 3.942)   
Non-Hispanic white - Other -0.023 (-3.307, 3.261)   
Non-Hispanic black - Mexican-American -4.297 (-7.468, -1.126)***   
Non-Hispanic black - Other -5.341 (-8.850, -1.832)***   
Mexican-American - Other -1.044 (-4.394, 2.305)   
    
Household Income (N=3625)  1.19 0.3121 
0 to $19,999 - $20,000 to $44,999 -1.227 (-4.576, 2.122)   
0 to $19,999 - $45,000 to $74,999 1.498 (-2.251, 5.246)   
0 to $19,999 - $75,000 to $99,999 -0.544 (-5.383, 4.295)   
0 to $19,999 - $100,000+ 0.169 (-3.997, 4.334)   
$20,000 to $44,999 - $45,000 to $74,999 2.724 (-0.741, 6.190)   
$20,000 to $44,999 - $75,000 to $99,999 0.683 (-3.940, 5.306)   
$20,000 to $44,999 - $100,000+ 1.395 (-2.517, 5.308)   
$45,000 to $74,999 – $75,000 to $99,999 -2.041 (-6.962, 2.879)   
$45,000 to $74,999 - $100,000+ -1.329 (-5.589, 2.931)   
$75,000 to $99,999 - $100,000+ 0.713 (-4.532, 5.957)   
    
Cotinine Levels (N=3865)  0.27 0.7666 
Non-Tobacco –Environmental Tobacco 0.5758 (-2.7415, 3.8932)   
Non-Tobacco -  Tobacco User -1.1707 (-5.9772, 3.6359)   
Environmental Tobacco – Tobacco User -1.7465 (-7.3679, 3.8749)   
    
***comparisons significant at the 0.05 level  
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4.2 Test Agreement 
           Agreement between the overweight BMI category (85
th
 to less than the 95
th
 
percentile) as a test/predictor and dyslipidemia of the three lipid factors is presented in 
Tables 8, 9 and 10.  The results for TC dyslipidemia as the positive outcome/disease are 
depicted in Table 8.  The sensitivity of overweight children as positive testers is low and 
ranges from 26.19 to 36.84%.  The highest sensitivity (36.84%) is in the 9 to 11 year old 
age group.  The specificity is moderate at 78.37%.  The PPV is low with the highest PPV 
in the 9 to 11 year old group at 12.07%.  The NPV is high at 94.09%. 
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Table 8   
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of Total 
Cholesterol in study participants (N = 2935) 
 
Overweight  
BMI 
Percentile  
Risk Factor 
Total Cholesterol 
Dyslipidemia 
 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive 
Predictive 
Value 
(95% CI) 
Negative 
Predictive 
Value 
(95% CI) 
 6 to 18 years old     
 Positive³ Negative⁴     
Positive¹ 59 593 30.41% 78.37% 9.05% 94.09% 
Negative² 135 2148 (0.240, 
0.374) 
(0.768, 
0.799) 
(0.070, 
0.115) 
(0.930, 
0.950) 
      
 6 to 8 years old     
 Positive³ Negative⁴     
Positive¹ 14 114 27.45% 82.57% 10.94% 93.59% 
Negative² 37 540 (0.159, 
0.417) 
(0.794, 
0.854) 
(0.061, 
0.177) 
(0.913, 
0.955) 
       
 9 to 11 years old     
 Positive³ Negative⁴     
Positive¹ 21 153 36.84% 77.73% 12.07% 93.68% 
Negative² 36 534 (0.245, 
0.507) 
(0.744, 
0.808) 
(0.076, 
0.179) 
(0.914, 
0.955) 
      
 12 to 15 years old     
 Positive³ Negative⁴     
Positive¹ 11 183 26.19% 76.84% 5.67% 95.14% 
Negative² 31 607 (0.139, 
0.420) 
(0.737, 
0.797) 
(0.029, 
0.099) 
(0.932, 
0.967) 
       
 16 to 18 years old     
 Positive³ Negative⁴     
Positive¹ 13 143 29.55% 76.56% 8.33% 93.78% 
Negative² 31 467 (0.168, 
0.452) 
(0.730, 
0.799) 
(0.045, 
0.138) 
(0.913, 
0.957) 
       
       
 
¹Overweight BMI = 85th to <95th percentile 
²Healthy Weight BMI = 5th to < 85th percentile 
³Total Cholesterol values >= 200 mg/dl 
⁴Total Cholesterol values  <200 mg/dl 
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           Test agreement statistics for HDL-C are presented in Table 9.  Sensitivity is 
highest in the 12 to 15 year old children at 38.76%.  Although the PPV (30.98%) is still 
low for this lipid factor, it is much higher than TC and non-HDL-C.  The highest PPV is 
with the 16 to 18 year old group at 37.82%.  Specificity and NPV is approximately 80% 
overall.   
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Table 9   
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of High 
Density Lipoprotein-Cholesterol (HDL-C) in study participants (N = 2935) 
 
Overweight  
BMI 
Percentile  
Risk Factor 
HDL-C Dyslipidemia 
 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive 
Predictive 
Value 
(95% CI) 
Negative 
Predictive 
Value 
(95% CI) 
 6 to 18 years old     
 Positive⁵ Negative⁶     
Positive¹ 202 450 33.11% 80.65% 30.98% 82.13% 
Negative² 408 1875 (0.294, 
0.370) 
(0.790, 
0.822) 
(0.275, 
0.347) 
(0.805, 
0.837) 
      
 6 to 8 years old     
 Positive⁵ Negative⁶     
Positive¹ 23 105 21.50% 82.44% 17.97% 85.44% 
Negative² 84 493 (0.141, 
0.304) 
(0.792, 
0.854) 
(0.117, 
0.257) 
(0.823, 
0.882) 
       
 9 to 11 years old     
 Positive⁵ Negative⁶     
Positive¹ 51 123 35.17% 79.47% 29.31% 83.51% 
Negative² 94 476 (0.274, 
0.435) 
(0.760, 
0.826) 
(0.227, 
0.367) 
(0.802, 
0.865) 
      
 12 to 15 years old     
 Positive⁵ Negative⁶     
Positive¹ 69 125 38.76% 80.89% 35.57% 82.92% 
Negative² 109 529 (0.316, 
0.463) 
(0.777, 
0.838) 
(0.288, 
0.427) 
(0.798, 
0.858) 
       
 16 to 18 years old     
 Positive⁵ Negative⁶     
Positive¹ 59 97 32.78% 79.54% 37.82% 75.70% 
Negative² 121 377 (0.260, 
0.402) 
(0.756, 
0.831) 
(0.302, 
0.459) 
(0.717, 
0.794) 
       
       
 
¹Overweight BMI = 85th to <95th percentile 
²Healthy Weight BMI = 5th to < 85th percentile 
⁵HDL-C values <40 mg/dl 
⁶HDL-C values >=40 mg/dl 
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           Table 10 includes results of test agreement between children in the overweight 
BMI percentile and dyslipidemia of non-HDL-C.  Nine to 11 year old children have the 
highest sensitivity (41.51%) and PPV (12.64%).  The specificity and NPV are 78.77% 
and 94.61% respectively. 
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Table 10   
Agreement between Overweight BMI Percentile as a Risk Factor and Dyslipidemia of Non-High 
Density Lipoprotein Cholesterol (Non-HDL-C) in study participants (N = 2935) 
 
Overweight  
BMI 
Percentile  
Risk Factor 
Non-HDL 
Dyslipidemia 
 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive 
Predictive 
Value 
(95% CI) 
Negative 
Predictive 
Value 
(95% CI) 
 6 to 18 years old     
 Positive⁷ Negative⁸     
Positive¹ 70 582 36.27% 78.77% 10.74% 94.61% 
Negative² 123 2160 (0.295, 
0.435) 
(0.772, 
0.803) 
(0.085, 
0.134) 
(0.936, 
0.955) 
      
 6 to 8 years old     
 Positive⁷ Negative⁸     
Positive¹ 14 114 41.18% 83.01% 10.94% 96.53% 
Negative² 20 557 (0.247, 
0.593) 
(0.800, 
0.858) 
(0.061, 
0.177) 
(0.947, 
0.979) 
       
 9 to 11 years old     
 Positive⁷ Negative⁸     
Positive¹ 22 152 41.51% 78.00% 12.64% 94.56% 
Negative² 31 539 (0.281, 
0.559) 
(0.747, 
0.810) 
(0.081, 
0.185) 
(0.924, 
0.963) 
      
 12 to15 years old     
 Positive⁷ Negative⁸     
Positive¹ 18 176 36.00% 77.49% 9.28% 94.98% 
Negative² 32 606 (0.229, 
0.508) 
(0.744, 
0.804) 
(0.056, 
0.143) 
(0.930, 
0.965) 
       
 16 to18 years old     
 Positive⁷ Negative⁸     
Positive¹ 16 140 28.57% 76.59% 10.26% 91.97% 
Negative² 40 458 (0.173, 
0.422) 
(0.730, 
0.799) 
(0.060, 
0.161) 
(0.892, 
0.942) 
       
       
 
¹Overweight BMI = 85th to <95th percentile 
²Healthy Weight BMI = 5th to < 85th percentile 
⁷Non-HDL-C values >=145 mg/dl 
⁸Non-HDL-C values <145 mg/dl 
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4.3 Simple Logistic Regression 
           Univariate logistic regression for each covariate is presented in Table 11.  Analysis 
for dyslipidemic TC reveals two covariates, age and BMI percentiles have significant 
findings.  Twelve to 15 year old youth are at decreased risk (OR= 0.7) for dyslipidemic 
TC in comparison to 6 to 8 year old children.  Overweight and obese children are 
respectively 1.6 and 2.0 times more likely to have abnormal TC values compared to 
healthy weight youth.   
           Significant findings for dyslipidemic HDL-C are numerous.  As children progress 
into higher age categories their odds ratios (OR= 1.3 to 1.9) for dyslipidemic HDL-C 
increase.  Overweight and obese youth are at increased risk (OR= 2.1 and 4.9 
respectively) for abnormal HDL-C.  Non-Hispanic blacks have less risk (OR= 0.6) in 
comparison to non-Hispanic whites.  Children from households in the highest income 
group are 40% less likely to have dyslipidemic HDL-C than those from the lowest 
income category.  Lastly, tobacco users have 2.1 times the risk for abnormal HDL-C 
compared to those not exposed to tobacco.   
           There are four covariates with significant findings for dyslipidemic non-HDL-C, 
age, BMI percentiles, race ethnicity and tobacco exposure.  Two age categories of 
children, 9 to 11 year olds and 16 to 18 year olds are at increased risk (OR = 1.6 and 1.7 
respectively) for abnormal non-HDL-C.  The overweight and obese youth again display 
increased risk (OR = 2.1 and 4.0 respectively) in comparison to normal weight children.  
The race ethnicity category of non-Hispanic black demonstrates a protective effect (OR = 
0.6) for non-HDL-C dyslipidemia.  Tobacco users have 1.9 times the risk for abnormal 
non-HDL-C. 
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Table 11  
Simple Logistic Regression for Dyslipidemias  
Categorical Variables Total Cholesterol 
OR (95% CI) 
HDL-C 
OR (95% CI) 
Non-HDL-C 
OR (95% CI) 
BMI Percentiles (N=3888)    
Healthy Weight¹ (Ref)    
Underweight² 1.55 (0.79, 3.03) 1.05 (0.65, 1.71) 0.81 (0.33, 2.03) 
Overweight³ 1.58 (1.15, 2.18)*** 2.06 (1.69, 2.51)*** 2.11 (1.55, 2.87)*** 
Obese⁴ 2.01 (1.52, 2.64)*** 4.91 (4.13, 5.84)*** 4.04 (3.14, 5.19)*** 
    
Gender (N=3888)    
Male (Ref)    
Female 0.86 (0.68, 1.09) 0.91 (0.79, 1.05) 0.82 (0.66, 1.02) 
    
 Age (N=3888)    
6 to 8 years (Ref)    
9 to 11 years 1.15 (0.84, 1.58) 1.33 (1.08, 1.64)*** 1.55 (1.12, 2.14)*** 
12 to 15 years 0.66 (0.47, 0.94)*** 1.49 (1.21, 1.83)*** 1.16 (0.83, 1.63) 
16 to 18 years 0.91 (0.65, 1.29) 1.94 (1.57, 2.40)*** 1.73 (1.24, 2.40)*** 
    
Race Ethnicity (N=3888)    
Non-Hispanic white (Ref)    
Non-Hispanic black 1.10 (0.80, 1.53) 0.56 (0.45, 0.69)*** 0.58 (0.42, 0.80)*** 
Mexican-American 0.94 (0.68, 1.29) 1.10 (0.92, 1.31) 0.81 (0.62, 1.07) 
Other 1.25 (0.90, 1.75) 0.97 (0.80, 1.19) 0.85 (0.63, 1.16) 
    
Household Income (N=3625)    
$0 to $19,999 (Ref)    
$20,000 to $44,999 1.11 (0.80, 1.55) 0.95 (0.78, 1.15) 1.07 (0.79, 1.43) 
$45,000 to $74,999 0.93 (0.64, 1.37) 0.89 (0.72, 1.11) 0.79 (0.55, 1.12) 
$75,000 to $99,999 1.07 (0.66, 1.72) 0.77 (0.57, 1.03) 0.80 (0.50, 1.26) 
$100,000+ 0.96 (0.63, 1.47) 0.61 (0.47, 0.79)*** 0.80 (0.54, 1.19) 
    
Tobacco Exposure (N=3865)    
Non-Exposed⁵ (Ref)    
Environmental Exposure⁶ 1.04 (0.71, 1.52) 1.18 (0.95, 1.48) 1.03 (0.72, 1.47) 
Tobacco User⁷ 1.22 (0.73, 2.04) 2.10 (1.56, 2.84)*** 1.90 (1.26, 2.88)*** 
    
***ORs significant at the 0.05 level 
Note: Dyslipidemias are defined as TC >=200 mg/dl, HDL-C < 40 mg/dl, and non-HDL-C >=145 mg/dl 
¹ Healthy Weight = BMI 5
th
 – 84
th
 percentile 
²Underweight =BMI <5
th
 percentile 
³Overweight = BMI 85
th
 to 94
th
 percentile 
⁴Obese = BMI >= 95
th
 percentile  
⁵Non-Tobacco Exposure = Cotinine level <1 ng/ml 
⁶Environmental Tobacco Exposure = Cotinine level 1 to 10 ng/ml 
⁷Tobacco User = Cotinine level > 10 ng/ml 
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4.4 Multivariate Logistic Regression  
          Multiple logistic regression analysis is conducted with inclusion of all independent 
covariates as depicted in Table 12.  There are 3605 participants in the sample who have 
data elements for all dependent and independent variables.  For TC dyslipidemia the 
same covariates remain significant with essentially no change in their odds ratios.  There 
is also very little change in the ORs of independent variables in the regression analysis 
for HDL-C dyslipidemia, with the exception of cotinine.  After controlling for all other 
categorical variables, tobacco users risk for dyslipidemic HDL-C decreases from 110 to 
62%.   
           Analyses for non-HDL-C dyslipidemia reveal a small increase in the ORs from the 
univariate to the multiple regression for obese youth, 4.0 to 4.3 respectively.  Mexican-
American youth are 30% less likely (OR = 0.7) to have abnormal non-HDL-C in the 
multiple regression, whereas in the univariate analysis this OR was not significant.  Also 
after controlling for other variables, the protective effect of non-Hispanic black race 
ethnicity status is increased slightly from OR= 0.6 to 0.5.   The increased risk associated 
with tobacco use is no longer significant in the multiple regression analysis.  All other 
significant ORs for non-HDL-C dyslipidemia remain essentially the same. 
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Table 12   
Multiple Logistic Regression for Dyslipidemias (N = 3605) 
Categorical Variables Total Cholesterol 
OR (95% CI) 
HDL-C 
OR (95% CI) 
Non-HDL-C 
OR (95% CI) 
BMI Percentiles    
Healthy Weight¹ (Ref)    
Underweight² 1.63 (0.83, 3.22) 0.93 (0.55, 1.55) 0.81 (0.32, 2.03) 
Overweight³ 1.53 (1.09, 2.16)*** 1.98 (1.60, 2.44)*** 2.19 (1.59, 3.04)*** 
Obese⁴ 2.11 (1.58, 2.81)*** 5.04 (4.19, 6.07)*** 4.28 (3.28, 5.58)*** 
    
Gender    
Male (Ref)    
Female 0.86 (0.67, 1.11) 0.97 (0.83, 1.13) 0.85 (0.67, 1.08) 
    
 Age    
6 to 8 years (Ref)    
9 to 11 years 1.18 (0.85, 1.65) 1.33 (1.05, 1.68)*** 1.60 (1.13, 2.27)*** 
12 to 15 years 0.66 (0.46, 0.95)*** 1.52 (1.21, 1.90)*** 1.22 (0.85, 1.74) 
16 to 18 years 0.86 (0.59, 1.26) 2.01 (1.57, 2.57)*** 1.66 (1.15, 2.41)*** 
    
Race Ethnicity    
Non-Hispanic white (Ref)    
Non-Hispanic black 1.08 (0.77, 1.53) 0.41 (0.32, 0.52)*** 0.48 (0.34, 0.68)*** 
Mexican-American 0.92 (0.65, 1.30) 0.92 (0.75, 1.14) 0.67 (0.49, 0.92)*** 
Other 1.14 (0.79, 1.65) 0.80 (0.64, 1.01) 0.74 (0.53, 1.05) 
    
Household Income    
$0 to $19,999 (Ref)    
$20,000 to $44,999 1.14 (0.81, 1.59) 0.86 (0.70, 1.06) 1.03 (0.76, 1.40) 
$45,000 to $74,999 0.98 (0.66, 1.44) 0.90 (0.71, 1.14) 0.78 (0.54, 1.13) 
$75,000 to $99,999 1.06 (0.65, 1.75) 0.73 (0.53, 1.00) 0.73 (0.45, 1.18) 
$100,000+ 1.11 (0.71, 1.72) 0.61 (0.45, 0.80)*** 0.81 (0.53, 1.23) 
    
Tobacco Exposure    
Non-Exposed⁵ (Ref)    
Environmental Exposure⁶ 1.33 (0.75, 2.39) 1.25 (0.97, 1.61) 0.93 (0.63, 1.37) 
Tobacco User⁷ 1.05 (0.70, 1.57) 1.62 (1.14, 2.31)*** 1.48 (0.91, 2.39) 
    
***ORs significant at the 0.05 level 
Note: Dyslipidemias are defined as TC >=200 mg/dl, HDL-C < 40 mg/dl, and non-HDL-C >=145 mg/dl 
¹Healthy Weight = BMI 5
th
 – 84
th
 percentile 
²Underweight =BMI <5
th
 percentile 
³Overweight = BMI 85
th
 to 94
th
 percentile 
⁴Obese = BMI >= 95
th
 percentile  
⁵Non-Tobacco Exposure = Cotinine level <1 ng/ml 
⁶Environmental Tobacco Exposure = Cotinine level 1 to 10 ng/ml 
⁷Tobacco User = Cotinine level > 10 ng/ml
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CHAPTER V 
DISCUSSION AND CONCLUSION 
5.1 Study Purpose 
            BMI at the 85
th
 percentile is the threshold to designate children and adolescents at 
risk for dyslipidemia and screening is recommended by the Expert Panel.  Although 
research has demonstrated a positive relationship between obesity and dyslipidemia and 
CVD, research specific to the relationship of overweight rather than obese youth and 
dyslipidemias is lacking. The purpose of this study was to examine associations between 
BMI at the 85th percentile or greater and dyslipidemias of total cholesterol, high-density 
lipoprotein cholesterol and non-high-density lipoprotein cholesterol in children and 
adolescents 6 through 18 years of age.   
5.2 Descriptive Data 
           For the three lipid factors studied, mean value differences between males and 
females are not significant.  The present study found that the mean concentration of TC 
among 6 to 18 year old youth is 158.7 mg/dl for males and 159.8 mg/dl for females. An 
elevated TC is found in 7.7% of the study participants. This is lower than published 
findings from other NHANES studies where approximately 10% of children ranging 
from 6 to 18 years of age had elevated TC levels. Consistent with earlier studies children 
in the younger age groups, 6 to 11 years of age have significantly higher mean values of 
TC in comparison to those 12 to 18 years old.  There is no significant difference found 
among race/ethnicity groups for TC in this study.  Whereas NHANES 1999-2006 
analysis conducted by Ford, Li, Zhao, and Mokdad (2009) found blacks had higher 
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concentrations of TC in comparison to whites and Mexican-Americans.  TC mean levels 
are significantly lower in healthy weight children compared to overweight (-3.45 [95% 
CI: -6.59, -0.31]) and obese children (-5.41 [95% CI: -8.26, -2.56]).  There are no 
significant differences in the mean TC values of participants based on household income 
or tobacco exposure.   
           The most obvious finding in the descriptive analysis is the high prevalence of 
HDL-C dyslipidemia.  In the present study dyslipidemic HDL-C values are found in 
27.4% of the participants.  This prevalence is much higher than another NHANES study 
from the 2001–2006 cycles, with published prevalence rates of approximately 19% for 
HDL-C at or below 40 mg/dl (Johnson et al., 2009).   
           In all but one age comparison group, the mean values of HDL-C decrease with 
age, most with significance. The exception is an increase in mean HDL-C value from the 
6 to 8 year old group to the 9 to 11 year old children.  Decreasing HDL-C values as 
children age into adolescence may indicate that dyslipidemia is increasing in this study 
group.  This is consistent with reports by Li et al. (2010) who found a much higher 
prevalence (57%) of HDL-C abnormality in adolescents, in comparison to 10 to 11 year 
old boys (24%).  In the present study, non-Hispanic blacks have significantly higher 
levels of mean HDL-C in comparison with all other race/ethnic groups.  This positive 
finding is also reflected in this group’s dyslipidemia prevalence.  Non-Hispanic blacks 
have the lowest HDL-C dyslipidemia (18.8%) compared to all other race ethnic groups 
(28.8 – 31.3%).  This finding of racial difference is consistent with an earlier NHANES’ 
study by Johnson et al. (2009). 
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           In the present study, HDL-C demonstrates significant mean differences for income 
and cotinine categories.  Participants from households at the lowest income level have 
mean HDL-C values approximately 2.17 mg/dl lower than the highest two income 
categories.  In regards to dyslipidemia development, it is reasonable to expect a 
socioeconomic effect.  Low-income groups are disadvantaged because they have less 
access to healthful foods, fewer physical activity options and generally experience stress 
related to their life condition, which can contribute to obesity development.  Study results 
for tobacco exposure are more dramatic, the changes in mean values of HDL-C decrease 
by a mean value of 5.11 md/dl for a tobacco user versus a non-tobacco user.  These 
findings concur with known risk factors for low HDL-C, which include smoking, lack of 
physical activity, excess body weight, and a diet high in refined carbohydrates (Harvard 
University, 2012). 
           Of all the variables analyzed for mean differences the most profound difference is 
found in the BMI percentile for HDL-C.  Mean HDL-C values consistently decrease, 
inversely to BMI percentile category increases, all with significance except for the 
underweight and healthy weight group.  Although not significant, the mean HDL-C value 
for the healthy weight group is still lower than the underweight group.   
           Non-HDL-C mean values are 106.1 for males and 107.1 for females.  In this study 
population 9.1% have abnormal non-HDL-C levels.  Significant results for mean values 
of this lipid factor involve age groups, race ethnicity and BMI percentile findings.  In 
regards to age groups, 12 to 15 year old children have significantly lower mean values 
than all other age groups.  Although specific research on non-HDL-C is lacking, this 
seems to be consistent with dyslipidemia studies in general that have found decreases in 
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cholesterol levels during puberty.  In this study sample, non-Hispanic blacks have 
considerably lower non-HDL-C values than all other groups studied ranging from 4.3 to 
5.3 mg/dl less. The results for BMI percentile categories and resulting difference among 
non-HDL-C mean values is significant for all combinations, except the healthy weight 
and underweight comparison.  In all cases, higher BMI percentile categories have higher 
mean non-HDL-C values in comparison to lower BMI percentile groups.    
5.3 Test Agreement 
             Predictiveness of BMI percentile overweight category (85
th
 through 94
th
 
percentile) at detecting dyslipidemia is evaluated by constructing two by two tables and 
calculating sensitivity, specificity, PPV and NPV for each of the three lipid factors.  A 
true positive test is defined as an overweight, but not obese child, who also has a positive 
lipid abnormality.  A false positive test is defined as an overweight, but not obese child 
with a negative test for lipid abnormality.  A true negative test is defined as a healthy 
weight (5
th
 through 84
th
 percentile BMI) child, who also has a negative test for lipid 
abnormality.  A false negative test is defined as a healthy weight child with a positive 
lipid abnormality.   
          Overall sensitivity for all three lipid factors is poor ranging from a low of 30.4% 
for TC to 36.3% for non-HDL-C.  Specificity in comparison is in a much more 
acceptable range of 78.4 to 80.7%.  The overall PPVs are very low at 9.1% for TC and 
10.7% for HDL-C.  The PPV for HDL-C demonstrates the most discrimination, but is 
low at 31.0%.  Test agreement statistics stratified by age categories produces interesting 
results.  For both TC and non-HDL-C, the 9 to 11 year old group has the highest 
sensitivity and PPVs.  Sensitivity for HDL-C increases commensurate with increasing 
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age categories, but the 12 to 15 year old group has the highest sensitivity (38.8%), 
whereas the 16 to 18 year olds has the highest PPV (37.8%).   The NPVs are high ranging 
from 82.1 to 94.7% and consistent with earlier research by Lee et al.   
           Test agreement analyses from previous research is not entirely consistent with the 
present study, however parameters used also differ which make them difficult to 
compare.  In the Project HeartBeat study, results included similar sensitivity and 
specificity levels, but higher PPV values for TC (26%) and HDL-C (24%) (Eissa, Wen, 
Mihalopoulos, Grunbaum, & Lararthe, 2009).  Lee et al., (2009) studied NHANES data 
from earlier years and reported much higher sensitivities, 51% for TC and 64% for HDL-
C and different PPVs 14% for TC and 11% for HDL-C.    
           The PPV for TC (9.1%) in the present study is lower than results (14%) from Lee 
and colleagues (2009).  The PPV for HDL-C (31.0%) is much higher than 11% found in 
the earlier study by Lee et al.  This may be a function of disease prevalence, as this study 
has a higher prevalence of HDL-C positive dyslipidemia than earlier research.  Positive 
predictive values increase in accuracy with increasing disease prevalence.  In the present 
study, prevalence of TC is 7.7% and for HDL-C 27.4%.  In contrast, Lee et al. reported 
higher TC prevalence (males 8.2%, females 10.2%) and much lower HDL-C prevalence 
(males 7.9%, females 5.4%).  The study by Lee et al. was on subjects from NHANES 
cycle years 1999-2004.  What is alarming here are the indications that HDL-C 
dyslipidemia prevalence may be substantially higher in US youth today compared to 
levels from only one decade ago.  
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5.4 Logistic Regression 
          The variables of BMI percentile and age dominate the associations found in both 
the simple and multivariate models.  The most profound results are in the BMI percentile 
categories.  For all three lipid factors, as children increase from overweight to obese 
categories their ORs for dyslipidemia increase.  These findings remain significant after 
controlling for gender, age, race ethnicity, income and tobacco exposure.  The risk for 
dyslipidemias among obese children is about two times that of overweight children (TC 
1.5 to 2.1; HDL-C 2.0 to 5.0; non-HDL-C 2.1 to 4.2).  These findings are consistent with 
studies that have shown increasing relative risk for dyslipidemias as BMI weight status 
categories increased (Freedman, Dietz, Srinivasan, Berenson, 1999; Holl et al., 2011).   
           Age related risk differences were found in this study.  The protective effect of the 
pubertal years is especially noted for TC with a significant OR = 0.7 for children 12 to 15 
years of age.  This value remains unchanged in the multiple logistic regression model 
after controlling for all other independent covariables.  Significant findings in the age 
categories for HDL-C and non-HDL-C also remain essentially unchanged in the multiple 
logistic regression model compared to the univariate analyses.  HDL-C odds ratios are 
higher as age categories increase (OR = 1.3 to 2.0).  For non-HDL-C, the OR for the 12 
to 15 year old group is less than the other age categories, but this finding is not 
significant.  These study findings are consistent with lipid value changes in relation to 
pubertal maturation also found by Bogalusa researchers and Kwiterovich et al., 1977 
(Berenson, Srinivasan, Cresanta, Foster, & Webber, 1981).            
           Although a number of large studies exist that have found increased TC values 
among black children in comparison to white children, this study did not find significant 
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differences among race ethnic groups for TC dyslipidemia (Freedman, Lee, Byers, 
Kuester, & Sell, 1992; Frerichs, Srinivasan, Webber, & Berenson, 1976; Webber et al., 
1991). Study results for TC are also inconsistent with a study by Resnicow and 
colleagues who found significantly higher TC values for both black and Hispanic 
children in comparison to white children (1989).  This study’s logistic regression analysis 
revealed significant findings in the race ethnicity categories for HDL-C and non-HDL-C 
dyslipidemias.  Non-Hispanic black subjects demonstrate a protective effect against 
HDL-C (OR = 0.4) and non-HDL-C (OR = 0.5) dyslipidemia in simple and multivariate 
logistic regression. After controlling for gender, age, BMI percentile, income and tobacco 
exposure, Mexican-Americans also have a significant decreased risk for non-HDL-C 
dyslipidemia (OR = 0.7).   
           Prior research and statistics exist which agree with this study’s findings in regards 
to the protective effect of non-Hispanic black race and HDL-C dyslipidemia.  NGHS 
researchers found decreased risk for African-American girls to exhibit unhealthful HDL-
C and 2012 Heart Disease and Stroke Statistics report much higher HDL-C mean values 
in non-Hispanic blacks compared to non-Hispanic whites and Mexican American boys 
and girls (Roger et al., 2012; Thompson et al., 2007).  However there are some 
inconsistencies with this study’s findings and prior research.  Bogalusa investigators 
found that non-HDL-C values were similar in black and white children, and Tortolero 
and colleagues found Mexican American boys had slightly lower HDL-C levels than non-
Hispanic white boys (Srinivasan, Myers, & Berenson, 2002; Tortolero et al., 1997). 
           In adults, socioeconomic status strongly predicts CVD risk factors.  A study of 
NHANES subjects from 1999-2008 found 6 to 17 year olds from low-income families 
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have higher prevalence of obesity, sedentary behavior and tobacco exposure, all of which 
are risk factors for abnormal low HDL-C levels (Ali et al., 2011).  In the present study, 
household income is included to account for socioeconomic influence on the outcome 
variables.  HDL-C is the only lipid factor with a significant finding.  Youth from homes 
with the highest income, greater than $100,000 a year, have 40% less risk for HDL-C 
dyslipidemia than children from the lowest income households.  This significant finding 
remains unchanged after controlling for BMI percentile, gender, age, race ethnicity and 
tobacco exposure.   
          In the present study, tobacco use risk demonstrates the most change between 
simple and multiple logistic regression analyses.  Tobacco users in simple logistic 
regression are at greater risk for HDL-C (OR = 2.1) and non-HDL-C (OR = 1.9) 
dyslipidemia.  This is consistent with previous studies that have found unfavorable 
changes in plasma lipids, including HDL-C, amongst youth who smoke tobacco (Clarke 
et al., 1986; Craig, Palomaki, Johnson, & Haddow, 1990; Glueck, Heiss, Morrison, 
Khoury, & Moore, 1981).   In the multivariate logistic regression, tobacco users risk for 
HDL-C abnormality reduces to OR = 1.6, but remains significant.  For non-HDL-C 
dyslipidemia, the risk from tobacco use is no longer significant (OR = 1.4 [95% CI: 0.9, 
2.4]) after controlling for all other covariables, BMI percentile, age, gender, race 
ethnicity, and income.   
5.5 Public Health Implications 
           Atherosclerotic CVD is the leading cause of death in the US and many risk factors 
that contribute to development of atherosclerosis begin in childhood.  The basis for 
screening children at risk for dyslipidemia is a function of primary prevention with the 
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goal to identify children at increased risk and to prevent CVD development by effectively 
managing risk factors.  Pediatric guidelines include targeted screening of children with 
BMIs at or greater than the 85
th
 percentile, but studies are lacking on associations of the 
overweight BMI category children and dyslipidemia.   
           Findings from this study have contributed to the body of knowledge concerning 
the relationship of youth BMI percentiles and dyslipidemias of TC, HDL-C and non-
HDL-C.  The results of this study provide additional statistics on the current prevalence 
of lipid levels in US youth in the context of gender, race, age, income, tobacco exposure 
and BMI percentiles.  Further information is presented on test agreement and association 
of BMI at the 85
th
 percentile and dyslipidemias of TC, HDL-C and non-HDL-C.  This 
study has contributed to the body of knowledge of BMI percentiles and relationships with 
abnormal levels of TC, HDL-C and non-HDL-C by examining a large sample of US 
youth.  Overall, results from this study can be used as a reference for additional studies 
and for planning intervention programs that aim to reduce the burden of CVD.   
5.6 Strengths and Limitations 
           The major strengths of this study are related to the source of the data NHANES.   
NHANES surveys are conducted in a manner that uphold the highest research standards 
and result in a high quality, comprehensive data bank of health information from a 
national representative sample of the US population.  Another major strength of this 
study is the relatively large sample size, which lends itself to greater statistical 
significance and representation from three distinct race/ethnicity groups.  Also due to the 
comprehensive nature of NHANES, it was possible to include considerable details related 
to the participants and to include non-HDL-C in the study.    
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           Limitations of this study are that not all race/ethnic groups could be represented.  
In particular, NHANES does not have a separate category for Asians and it would have 
been informative to include this group in the analysis.  In some regards, it was difficult to 
include confounders due to nuances of NHANES.  Thus the study does not include 
variables related to hypertension and diabetes, which are known high risk factors for 
atherosclerosis development.  There were limitations in the selection of lipid factors 
selected for the study.  Triglycerides and low density lipoprotein-cholesterol are not 
included because this would have decreased the sample size and limited the age of the 
study sample to those over 12 years.  NHANES is a cross sectional survey and there was 
only one laboratory value for each lipid factor.  Individual lipid levels can vary and 
evaluation should not be based on a single laboratory test.  Thus, a limitation is that only 
one value per lipid factor was available for this study. 
5.7 Recommendations 
           Obesity is clearly established as a CVD risk factor, however studies on overweight 
youth and dyslipidemia are lacking.  This study has contributed to the body of knowledge 
of youth risk for dyslipidemias according to BMI weight status categories.  Results of this 
study support continued screening of children and adolescents in the overweight 
category, as both overweight and obese youth were found to be at increased risk for 
dyslipidemias.  Although targeted screening of overweight children was not supported by 
results of the test agreement analysis, these analyses may have been problematic due to 
the multifactorial basis for dyslipidemia and low dyslipidemia prevalence found in the 
sample.  Further research on associations of pediatric overweight, obesity and 
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dyslipidemia, and specifically studies on the effectiveness of BMI at the 85
th
 percentile as 
a predictor of dyslipidemias in youth are warranted.   
          In regards to race and ethnicity, most studies have been conducted on non-Hispanic 
whites and non-Hispanic blacks.  Additional research on a broader range of race/ethnic 
groups is needed, especially in US Hispanic and Asian populations.  Further studies are 
needed to assess the relationship of tobacco use and dyslipidemias.   Tobacco use is a 
known risk factor for dyslipidemias, however in this study the multivariate regression 
analysis revealed significant findings only for HDL-C.   
           It is important to continue surveillance of distinct dyslipidemia prevalence among 
our youth.  Full lipid profiles are more revealing.  Results of the present study found 
differences in TC, HDL-C and non-HDL-C dyslipidemia prevalence, as well as 
differences in dyslipidemias according to age and race ethnicity groups.  The prevalence 
of HDL-C was alarming, as it was much higher in this study cohort than had been 
reported in earlier research.  These findings validate the importance of monitoring lipid 
factors and dyslipidemia prevalence in our youth.   
           The obesity epidemic is of utmost concern and the evidence base is strong that 
obesity is a major risk factor for CVD, as well as other risk factors for CVD such as 
dyslipidemias and diabetes.  Additional studies on the effects of physical inactivity and 
diet in regards to dyslipidemias could add valuable information for both risk conditions.   
Further studies may reveal a genetic component related to ethnic origin and responses to 
diet or physical activity levels.  For example, some groups may have less tolerance for fat 
intake or respond more positively to physical activity.   
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           Studies that analyze the effects of screening youth and detecting dyslipidemias, 
which may lead to identifying additional family members with dyslipidemias, could 
reveal a secondary benefit from screening youth, in that we could ameliorate the health 
consequences of CVD in two generations simultaneously.  This could also lead to studies 
that examine the relationship of a mother’s or father’s dyslipidemia status and those of 
their children.  Prospective studies on children through adulthood, which examine their 
CVD risk status, how risk status changes over time, if knowledge of risks effects 
behavior, the effects of intervention and incidence of CVD, would ultimately offer the 
most credible information on CVD screening in youth and planning CVD prevention 
programs.     
5.8 Conclusion 
           This study has provided further evidence that not only obese, but overweight 
children are at greater risk for dyslipidemias of TC, HDL-cholesterol and non-HDL-
cholesterol.  Findings show the importance of analyzing individual lipid factors, 
especially HDL-C in contrast to only obtaining a TC value, as the components offer a 
much better picture of the individual’s lipid status and each lipid factor seems to be 
affected by risk factors differently.  As in earlier reported research, BMI at the 85
th
 
percentile did not provide good discrimination in detecting children and adolescents with 
dyslipidemia.  Thus despite this study’s findings that overweight children are at increased 
risk for dyslipidemias, overweight status and perhaps even obesity, may not be strong 
enough risk factors individually, to translate into a good screening indice for youth 
dyslipidemia.  Use of BMI at the 85
th
 percentile as a threshold for dyslipidemia screening 
in youth warrants further consideration.  Considering age-related prevalence and the lack 
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of predictiveness of major screening criteria, such as family history and BMI at the 85
th
 
percentile, the recent change in recommendations by the Expert Panel to include 
universal screening of 9 to 11 year old children is affirmed and may obviate the need to 
target screen overweight children for dyslipidemia.  
           Atherosclerotic cardiovascular disease is the leading cause of death in the US and 
CVD is a chronic condition that begins in youth.  Public health primary prevention goals 
aim to reduce the burden of CVD by reducing risk factors early in life.  The high 
prevalence of overweight and obese US youth is a public health concern for the 
development of chronic diseases, including CVD.  The results of this study, and other 
research, have demonstrated that overweight and obese youth are at increased risk for 
dyslipidemias.  It is important to continue public health efforts to reduce obesity 
prevalence, as well as other risk factors, which lead to adult CVD.  Public health 
surveillance and study of lipid levels in youth and risk behaviors that can lead to 
dyslipidemias, atherosclerosclerosis and CVD is vital, in the effort to better understand 
this disease process, promote prevention programs and ultimately to reduce the burden of 
cardiovascular disease.
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